Document:

<PAGE>
                                                                   EXHIBIT 10.16
                          EXCLUSIVE LICENSE AGREEMENT

                                    between

                  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

                                      and

                                  NANOSYS INC.

                                      for

               METHODS OF FABRICATING NANOSTRUCTURES AND NANOWIRES
                         AND DEVICES FABRICATED THEREFROM

                              UC Case No. 2001-190

                                                       U.C. AGREEMENT
                                                       CONTROL NUMBER
                                                        2002-04-0782

<PAGE>
                               TABLE OF CONTENTS

Article No.     Title                                                       Page

BACKGROUND...................................................................  2

1.  DEFINITIONS..............................................................  3

2.  LIFE OF PATENT EXCLUSIVE GRANT...........................................  5

3.  SUBLICENSES..............................................................  5

4.  PAYMENT TERMS............................................................  8

5.  LICENSE ISSUE FEE......................................................... 9

6.  EARNED ROYALTIES AND MINIMUM ANNUAL ROYALTIES............................  9

7.  DUE DILIGENCE............................................................ 11

8.  PROGRESS AND ROYALTY REPORTS............................................. 12

9.  BOOKS AND RECORDS........................................................ 14

10. LIFE OF THE AGREEMENT.................................................... 14

11. TERMINATION BY THE REGENTS............................................... 15

12. TERMINATION BY LICENSEE.................................................. 15

13. DISPOSITION OF LICENSED PRODUCT ON HAND UPON TERMINATION................. 15

14. USE OF NAMES AND TRADEMARKS.............................................. 16

15. LIMITED WARRANTY......................................................... 16

16. PATENT PROSECUTION AND MAINTENANCE....................................... 17

17. PATENT MARKING........................................................... 19

18. PATENT INFRINGEMENT...................................................... 19

19. INDEMNIFICATION.......................................................... 20

20. NOTICES.................................................................. 21

21. ASSIGNABILITY............................................................ 22

22. NO WAIVER................................................................ 23

23. FAILURE TO PERFORM....................................................... 23

24. GOVERNING LAWS........................................................... 23

25. PREFERENCE FOR U.S. INDUSTRY............................................. 23

26. GOVERNMENT APPROVAL OR REGISTRATION...................................... 23

27. EXPORT CONTROL LAWS...................................................... 23

28. SECRECY.................................................................. 24

29. MISCELLANEOUS............................................................ 25

                                       1

<PAGE>
                          EXCLUSIVE LICENSE AGREEMENT

                                      for

                  METHODS OF FABRICATING NANOSTRUCTURES AND NANOWIRES
                             AND DEVICES FABRICATED THEREFROM

     This exclusive license agreement ("Agreement") is made effective May 31,
2002 ("Effective Date"), between The Regents of the University of California, a
California corporation, having its statewide administrative offices at 1111
Franklin Street, 12th Floor, Oakland, California 94607-5200 ("The Regents"),
and Nanosys, Inc, a Delaware corporation, having a principal place of business
at 200 Boston Avenue, Suite 4700, Medford, MA 02155 ("Licensee").

                                   BACKGROUND

     A. Certain inventions, generally characterized as Methods of Fabricating
Nanostructures and Nanowires and Devices Fabricated Therefrom (collectively
"Invention"), were made in the course of research at the University of
California, Berkeley, the University of California, Santa Cruz, and the Lawrence
Berkeley National Laboratory and are covered by Regents' Patent Rights as
defined below.

     B. The development of the Invention was sponsored in part by the National
Science Foundation and the Department of Energy and, as a consequence, this
license is subject to overriding obligations to the United States ("U.S.")
Federal Government under 35 U.S.C. Sections 200-212 and applicable regulations
including a non-exclusive paid up license for or on behalf of the United States
throughout the world.

     C. Licensee and The Regents have executed a Letter of Intent (UC Control
No. 2002-30-0126) dated September 13, 2001.

     D. Licensee and The Regents have executed a Secrecy Agreement (UC Control
No. 2002-20-0444) effective February 8, 2002.

     E. Licensee wishes to obtain rights from the Regents for the exclusive
commercial development, use and sale of products from the Invention, and the
Regents is willing to grant those

                                                       U.C. AGREEMENT
                                                       CONTROL NUMBER
                                                       2002-04-0782

                                       2
<PAGE>
rights so that the Invention may be developed to its fullest and the benefits
enjoyed by the general public.

     F. Licensee is a "small business firm" as defined in 15 U.S.C. Section 632.

     G. Both parties recognize and agree that royalties due under this
Agreement on products and methods will be paid by Licensee on both pending
patent applications and issued patents.

                                 -- oo 0 oo --

     In view of the foregoing, the parties agree:

1.   DEFINITIONS

     1.1 "Affiliate" means any corporation or other business entity in which
Licensee owns or controls, directly or indirectly, at least fifty percent (50%)
of the outstanding stock or other voting rights entitled to elect directors or
in which Licensee is owned or controlled directly or indirectly by at least
fifty percent (50%) of the outstanding stock or other voting rights entitled to
elect directors; but in any country where the local law does not permit foreign
equity participation of at least fifty percent (50%), then an "Affiliate"
includes any company in which Licensee owns or controls, or is owned or
controlled by, directly or indirectly, the maximum percentage of outstanding
stock or voting rights permitted by local law.

     1.2 "Licensed Method" means any method, the use of which would constitute,
but for the license granted to Licensee under this Agreement, an infringement
of any Valid Claim within Regents' Patent Rights.

     1.3 "Licensed Product" means any material that is produced by the Licensed
Method or that the sale of which would constitute, but for the license granted
to Licensee under this Agreement, an infringement of any Valid Claim within
Regents' Patent Rights.

     1.4 "Net Sales" means the total amounts received by Licensee or its
Affiliates from the Final Sale of Licensed Product or Licensed Method to an
independent, unaffiliated third party, less the sum of the following actual and
customary deductions where applicable; [*** Redacted], [*** Redacted]; [***
Redacted], [*** Redacted], [*** Redacted], [*** Redacted] or other [***
Redacted] or [*** Redacted] on particular sales (excepting [*** Redacted] on
that portion of the [*** Redacted] by Licensee or its Affiliates, or [***
Redacted]; and in no case will the [*** Redacted] deducted be greater than [***
Redacted]); [*** Redacted]; and [*** Redacted] to customers because of [***
Redacted]. Final Sale means the sale which is the [*** Redacted] of Regents'
Patent Rights performed by Licensee or an Affiliate, regardless of whether
Licensee or an Affiliate had control over prior infringing acts.

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       3
<PAGE>

     For purposes of calculating Net Sales, any distribution or transfer between
Licensee (or an Affiliate) and a sublicensee for end use by the recipient (which
event is the last act of infringement of Regents' Patent Rights) will be
considered a Final Sale at the price normally charged to independent,
unaffiliated third parties.

     In the event that a Licensed Product is sold as a combination product
containing Licensed Product and one or more other components not covered by
Regents' Patent Rights, Net Sales shall be calculated by multiplying the
amounts received from the Final Sale of the combination product to an
independent, unaffiliated third party by the fraction [*** Redacted] where A is
the [*** Redacted] of Licensed Product sold separately by Licensee and B is the
[*** Redacted] of such other components of the combination product sold
separately by Licensee during the relevant royalty payment period. In the event
a substantial number of such separate sales were not made during the relevant
royalty payment period, the Net Sales of such combinations shall be [***
Redacted] between such Licensed Product and such other product(s), service(s)
and component(s) based on their relative importance or value.

     If the Licensed Product is a part or an optional component of a system,
Licensee agrees that any discounting of price will be done uniformly and equally
across the system so that the Licensed Product is not discounted any more than
the system as a whole.

     1.5 "Regents' Patent Rights" means The Regents' interest in the following
subject matter:

<Table>
<Caption>
UC Case Number                U.S. Application Number            Filing Date
--------------                -----------------------            -----------
<S>                                <C>                         <C>
2001-190-1                          60/280,676                  March 30, 2001
2001-190-2                          60/349,206                  January 15, 2002
2001-190-3                          10/112,578                  March 29, 2002
2001-190-4                          10/112,698                  March 29, 2002
</Table>

     and continuing applications thereof including divisions, continuations,
continued prosecution applications, or substitutions, and continuation-in-part
applications or patents of additions (to the extent claims of such
continuations-in-part or patents of additions are supported by the parent
application); any patents on said applications including reissues,
reexaminations, registrations, renewals and extensions; any corresponding
foreign applications or patents; and any other patents

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       4
<PAGE>
and patent applications worldwide based upon and claiming any inventions
described in the above patents and patent applications.

     1.6  "Valid Claim" shall mean either (i) a claim of an issued patent that
has not expired or been held unenforceable or invalid by a final judgment or
decision of a court or other government agency of competent jurisdiction from
which no appeal has or can be taken, and which has not been admitted to be
invalid or unenforceable through reissue, disclaimer or otherwise, or (ii) a
claim of a pending patent application that is being prosecuted in good faith
consistent with customary patent practice, which has not been abandoned or
finally rejected without the possibility of appeal or refiling and has been
pending for less than [*** Redacted] ([*** Redacted]) [*** Redacted] in the
United States or [*** Redacted] ([*** Redacted]) [*** Redacted] in foreign
countries after its earliest priority date.

2.   LIFE OF PATENT EXCLUSIVE GRANT

     2.1  Subject to the limitations set forth in this Agreement, The Regents
grants to Licensee a world-wide license under Regents' Patent Rights to make,
have made, use, sell, offer to sell and import Licensed Products and to
practice Licensed Methods to the extent permitted by law, in each case for any
and all fields of use.

     2.2  Except as otherwise provided in this Agreement, the license granted
in Paragraph 2.1 is exclusive for the life of the Agreement.

     2.3  The license granted in Paragraphs 2.1 and 2.2 is subject to all the
applicable provisions of any license to the U.S. Government executed by The
Regents prior to the Effective Date and is subject to the overriding obligations
to the U.S. Government under 35 U.S.C. Sections 200-212 and applicable
governmental implementing regulations.

     2.4  The Regents reserves the right to use the Invention and technology of
the Patent Rights for educational and non-commercial research purposes
including publication of research results and sharing such research results,
such Invention and technology with other educational and non-profit
institutions for their use of similar scope.

3.   SUBLICENSES

     3.1  The Regents also grants to Licensee the right to issue sublicenses to
third parties to make, have made, use, sell, offer to sell and import Licensed
Product and to practice Licensed Method, and other sublicenses of or within the
scope of the license granted under Article 2, as long as Licensee has current
exclusive rights thereto under this Agreement. To the extent applicable,

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       5
<PAGE>
sublicenses must include all of the rights of and obligations due to The
Regents and, if applicable, the U.S. Government contained in this Agreement.

     3.2  Licensee shall promptly provide The Regents with a copy of the
relevant portion of each sublicense issued (which shall include but not be
limited to information with an impact on financial terms or other requirements
of this Agreement), collect and guarantee payment of all payments due The
Regents from sublicensees and summarize and deliver all reports due The Regents
from sublicensees. All such information shall be deemed the Confidential
Information of Licensee pursuant to the terms of Article 28 (Secrecy).

     3.3  (a) If after five (5) years from the Effective Date, The Regents
becomes aware of any field of use that Licensee is not pursuing with respect to
the Regents' Patent Rights, and a third party has an interest and a detailed
plan for pursuing such field of use (which is not overlapping or competitive
with any field pursued by Licensee for Regent's Patent Rights), The Regents may
notify Licensee of such third party's interest (such third party, the "Potential
Sublicensee", and such field, the "New Field").

     (b) In the event of a notice under Section 3.3(a), Licensee shall have a
period of ninety (90) days thereafter to notify The Regents (such notice, its
"New Field Plans") if: (i) it or its sublicensees are then currently pursuing
the New Field (or an overlapping or competitive field of use for Regent's Patent
Rights); or (ii) it or its sublicensees are planning to pursue the New Field (or
an overlapping or competitive field of use for Regent's Patent Rights) in the
future; or (iii) it desires to directly sublicense such Potential Sublicensee.
If Licensee notifies The Regents of case (i) or (ii) above, Licensee or its
sublicensee shall provide The Regents with its development plan therefor within
four (4) months thereafter. If Licensee notifies The Regents of case (iii)
above, The Regents shall direct the Potential Sublicensee to negotiate in good
faith with Licensee for a sublicense.

     (c) If (i) Licensee has not notified The Regents of its New Field Plans
within the above ninety (90) day period or Licensee has not provided The Regents
with a development plan therefor within the above four (4) month period, as
required in Section 3.3(b), or (ii) Licensee and the Potential Sublicensee are
unable to reach a sublicense agreement, and the Potential Sublicensee has
negotiated in good faith with Licensee, or (iii) Licensee fails to diligently
proceed in good faith with the development, manufacture, and sale of Licensed
Product in New Field according to the development plan of 3.3(b), as updated
from time to time with the approval of The Regents, then The Regents may issue a
non-exclusive sublicense to the Potential Sublicensee, limited to the New

                                       6
<PAGE>
Field; provided that Licensee does not notify The Regents that it owns or
controls issued patent claims, which patent claims are valid and would dominate
use of the Regents' Patent Rights in the New Field. Such sublicense to the
Potential Sublicensee shall have royalty rate(s) (including with respect to
sublicensing revenue) which are no more favorable than those set forth herein.

     3.4  Upon termination of this Agreement for any reason, all sublicenses of
The Regents' Patent Rights not then currently in material breach, will be
assigned to The Regents, at the request of the sublicensee; provided that the
duties of The Regents under the assigned sublicenses will not be greater than
the duties of The Regents under this Agreement, and the rights of The Regents
under the assigned sublicenses will not be less than the rights of The Regents
under this Agreement.

     3.5  Payment to The Regents for sublicenses of Regent's Patent Rights
issued by Licensee to non-Affiliate third parties shall include payment of [***
Redacted]% of all fees, royalties and other revenues obtained by the Licensee
from such sublicense, but excluding (a) income received by Licensee as payment
or reimbursement for research, development or costs incurred by or for Licensee
associated with materials, equipment or clinical testing or patent expenses (as
reasonably allocated, and according to fair market value if readily available);
(b) amounts received for securities (equity or debt), or services, products,
equipment (as reasonably allocated, and according to fair market value if
readily available); (c) amounts in consideration for licenses or other rights
under intellectual property other than Regents' Patent Rights, as reasonably
allocated; (d) amounts in consideration for the sale of all or substantially all
of the business or assets of Licensee, whether by merger, acquisition of stock
or assets or otherwise; and (e) any governmental charges, including withholding
or other taxes (but not income taxes), paid or payable by Licensee on amounts
received in consideration for a sublicense under Regents' Patent Rights. In the
event that such payment to Licensee for issuance of a sublicense includes a
non-cash component, including but not limited to equipment and cross-licenses,
the Regents shall be paid [*** Redacted]% of the value of the non-cash component
(excluding deductions (a) to (e) above). Upon request, Licensee shall provide
the Regents with its calculation of the above amounts, along with supporting
documentary evidence.

     3.6  Implicit in the [*** Redacted]% figure of Paragraph 3.5 above is the
assumption that Licensee will add significant value to Regents' Patent Rights
through its own development efforts. In the event that Licensee issues a
sublicense that does not include a contribution of Licensee's development or
Licensee has not added significant value, payment to The Regents for that
sublicense shall be [*** Redacted]% rather than [*** Redacted]%. Without
limiting the generality of such language, Licensee shall be deemed to have

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       7
<PAGE>

contributed development or added significant value if Licensee sublicenses other
patent rights or provides other substantive intellectual property or technology
(e.g. manufacturing know-how, prototypes, breadboards, components or tools) in
connection with sublicensing the Regents' Patent Rights, or Licensee has spent
at least seven hundred and fifty thousand dollars ($750,000) developing Licensed
Products or Licensed Methods (within the meaning stated in Section 7.3), which
development efforts are in or applicable to the field of use being sublicensed.

4.   PAYMENT TERMS

     4.1  Paragraphs 1.2, 1.3 and 1.5 define Licensed Method, Licensed Product
and Regents' Patent Rights, so that royalties are payable on products and
methods covered by Valid Claims of both pending patent applications and issued
patents. Royalties will accrue in each country for the duration of Regents'
Patent Rights in that country and are payable to The Regents in the next
royalty report after payment for the Licensed Product is received by Licensee
or Affiliate.

     4.2  Licensee shall pay to The Regents earned royalties quarterly on or
before February 28, May 31, August 31 and November 30 of each calendar year.
Each payment will be for earned royalties accrued within Licensee's most
recently completed calendar quarter.

     4.3  All monies due The Regents are payable in U.S. dollars. Licensee is
responsible for all bank transfer charges. When Licensed Product is sold for
monies other than U.S. dollars, Licensee shall first determine the earned
royalty in the currency of the country in which Licensed Product was sold and
then convert the amount into equivalent U.S. funds, using the exchange rate
quoted in The Wall Street Journal on the last business day of the reporting
period.

     4.4  Royalties earned on sales occurring in any country outside the U.S.
may not be reduced by any taxes, fees or other charges imposed by the
government of such country on the payment of royalty income. Notwithstanding
the foregoing, all payments made by Licensee in fulfillment of The Regents' tax
liability in any particular country will be credited against earned royalties
or fees due The Regents for that country.

     4.5  If at any time legal restrictions prevent the prompt remittance of
royalties by Licensee from any country where a Licensed Product is sold, then
Licensee shall convert the amount owed to The Regents into U.S. funds and shall
pay The Regents directly from its U.S. source of funds for as long as the legal
restrictions apply.

     4.6  If any patent or patent claim within Regents' Patent Rights is held
invalid in a final decision by a court of competent jurisdiction and last
resort and from which no appeal has or can be

                                       8
<PAGE>
taken, then all obligation to pay royalties based on that patent or claim or
any claim patentably indistinct therefrom will cease as of the date of final
decision. Licensee will not, however, be relieved from paying any royalties
that accrued before the final decision or that are based on another patent or
claim not involved in the final decision.

     4.7  No royalties may be collected or paid on Licensed Product sold to the
account of the U.S. Government, or any agency thereof, as provided for in the
license to the Government.

     4.8  In the event payments, rebillings or fees are not received by The
Regents when due, Licensee shall pay to The Regents interest charges at a rate
of ten percent (10%) per annum. Interest is calculated from the date payment was
due until actually received by The Regents.

5.  LICENSE ISSUE FEE

          Licensee shall pay to The Regents a license issue fee of [***
Redacted] ([*** Redacted]) within thirty (30) days after the Effective Date.
Licensee shall, as a one-time payment, pay The Regents an additional [***
Redacted] ($[*** Redacted]) within thirty (30) days after the first issuance of
a patent within the Regents' Patent Rights. These fees are non-refundable,
non-cancelable and are not an advance against royalties.

6.  EARNED ROYALTIES AND MINIMUM ANNUAL ROYALTIES

     6.1  Licensee shall also pay to The Regents an earned royalty of [***
Redacted] percent ([*** Redacted]%) of the Net Sales of Licensed Product or
Licensed Method.

     6.2  In the event that Licensee must pay additional royalties on the sale
of a Licensed Product or Licensed Method to one or more independent,
unaffiliated third parties (who have patent rights that are required to make or
sell the Licensed Product or Licensed Method), and the sum of royalties to be
paid by Licensee (prior to any reductions) to all such third parties (such
royalty for each individual third party, a "Third Party Royalty" and the sum,
the "Total Royalties") would exceed [*** Redacted] percent ([*** Redacted]%),
then The Regents will agree to reduce the royalties due on that Licensed Product
or Licensed Method by multiplying with the ratio [*** Redacted], where X is the
percentage value of the Total Royalties; provided that each such third party
also agrees to a reduction of its royalty rate to an amount equal to or less
than Y, where Y is equal to the corresponding Third Party Royalty multiplied
with the ratio [*** Redacted]. If any such third party does not reduce its
royalty rate to at least Y, then The Regents shall reduce its royalty rate by a
percentage equal to the minimum reduction

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       9
<PAGE>
(percentage wise) agreed to by such third parties. However, in no case shall
royalties due The Regents according to Paragraph 6.1 be reduced to less than
[*** Redacted] percent ([*** Redacted]%).

     For example: If Licensee licenses intellectual property rights from two
other entities E1 and E2 for use in Licensed Products, at the respective royalty
rates of [*** Redacted]% and [*** Redacted]%, the total royalties before a
proportionate reduction is equal to [*** Redacted]. The Regents will then agree
to reduce its royalty rate at a ratio of [*** Redacted], i.e. to [***
Redacted]%, if the other licensing entities E1 and E2 agree to reduce their
royalty rate to [*** Redacted]% or below.

<Table>
<Caption>
Licensing entity       Initial royalty rate      ratio      Reduced royalty rate
<S>                    <C>                   <C>            <C>
The Regents            [*** Redacted]%       [*** Redacted] [*** Redacted]%

E1                     [*** Redacted]%       [*** Redacted] [*** Redacted]%

E2                     [*** Redacted]%       [*** Redacted] [*** Redacted]%

Total:                 [*** Redacted]%       [*** Redacted] [*** Redacted]%
</Table>

     6.3  To implement a reduction in royalties due under Paragraph 6.2,
Licensee will provide written evidence of license agreements with third parties
that include the third parties' agreement to a reduction in royalties due to
them sufficient under Paragraph 6.2. Licensee shall provide written evidence of
payments made to such third parties under such license agreements.

     6.4  Licensee shall pay to The Regents a minimum annual royalty as follows:

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    [*** Redacted] dollars ($[*** Redacted]) in [*** Redacted];

     -    and beginning in [*** Redacted] and for the remaining life of Regents'
Patent Rights, Licensee shall pay to The Regents a minimum annual royalty of
[*** Redacted] dollars ($[*** Redacted]).

     The minimum annual royalty will be paid to The Regents by November 30 of
each year and will be credited against the earned royalty due for the calendar
year in which the minimum payment was made.

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       10
<PAGE>
     6.5  In no event shall more than one royalty be payable hereunder with
respect to any particular Licensed Product unit or practice of Licensed Method.
No royalty shall be payable under this Agreement with respect to sales of
Licensed Products among Licensee, its Affiliates or sublicensees for resale;
nor shall a royalty be payable hereunder with respect to the practice of
Licensed Methods or the sale or provision of Licensed Products as samples, for
research and development efforts by or for Licensee, or transactions that are
not a full commercial sale (i.e. for transactions that are at fully burdened
cost or for which there is no profit).

     6.6  The amounts payable under this Agreement are based on the parties'
understanding that The Regents owns or controls sufficient right, title and
interest in each of the patent rights listed in the table of Section 1.5 to
grant Licensee an exclusive license thereunder apart from the license to the
government hereunder. In the event The Regents breaches this Section 6.6 (i.e.
it does not have such ownership or control), then the parties shall negotiate
in good faith to appropriately reduce the amounts payable under this Agreement,
in addition to any other remedies which may be available.

7.   DUE DILIGENCE

     7.1  Licensee, upon execution of this Agreement, shall diligently proceed
with the development, manufacture and sale of Licensed Product and shall
earnestly and diligently endeavor to market the same within a reasonable time
after execution of this Agreement and in quantities sufficient to meet market
demands, each to the extent commercially sound and technically viable.

     7.2  Licensee shall endeavor to obtain all necessary governmental
approvals for the manufacture, use and sale of Licensed Product.

     7.3  Licensee shall:

          7.3.1  Employ one (1) employee (or the equivalent if employees' time
                 is devoted to multiple projects) to work solely on Invention by
                 December 31, 2003;

          7.3.2  Employ three (3) employees (or the equivalent if employees'
                 time is devoted to multiple projects) to work solely on
                 Invention by December 31, 2004;

          7.3.3  use commercially reasonable efforts to achieve a first
                 commercial sale of a Licensed Product or Licensed Method by
                 December 31, 2008;

          7.3.4  reasonably fill the market demand for Licensee's Licensed
                 Products following commencement of marketing and at any time
                 during the exclusive period of this Agreement, to the extent
                 commercially sound and technically viable;

                                       11
<PAGE>

          7.3.5  spend at least two hundred fifty thousand dollars ($250,000) on
                 development of Licensed Product or Licensed Method by December
                 31, 2003;

          7.3.6  spend at least five hundred thousand dollars ($500,000)
                 annually on development of Licensed Product or Licensed Method
                 starting in 2004, until the first commercial sale of a Licensed
                 Product or Licensed Method.

     It is understood that "working solely on" the Invention and "developing"
Licensed Products or Licensed Methods shall include working on, developing or
acquiring technology reasonably necessary for the commercial and/or technical
viability of the Regent's Patent Rights or any Licensed Product or Licensed
Method (e.g. interface, electronic packaging, device integration, materials
and/or fabrication technologies).

     7.4  If Licensee is unable to perform Sections 7.1, 7.2 or 7.3, then The
Regents has the right to reduce Licensee's exclusive license to a nonexclusive
license (in the event Licensee is unable to perform Sections 7.3.1, 7.3.2,
7.3.5, 7.3.6, The Regents may, at its option, terminate the license under
Section 11 or render the license non-exclusive) upon written notice; provided in
each case, that The Regents' has notified Licensee of its breach of such
Sections, and has negotiated in good faith with Licensee with respect to a
mutually acceptable plan to remedy such breach, and Licensee then fails to
perform such mutually acceptable plan. If the parties cannot reach agreement on
a mutually acceptable plan, the mutually acceptable plan shall be for Licensee
to thereafter: (a) continue to be subject to all of its diligence requirements,
and (b) spend an extra fifty percent (50%) of the amounts it is obligated to
spend over the same period under Sections 7.3.5 and 7.3.6. Licensee's compliance
with the mutually acceptable plan shall be subject, as a minimum, to Regents'
verification six (6) months thereafter of Licensee's progress. This right, if
exercised by The Regents, supersedes the rights granted in Article 2 (Life of
Patent Exclusive Grant).

8.   PROGRESS AND ROYALTY REPORTS

     8.1  Beginning September 30, 2003, and semi-annually thereafter, Licensee
shall submit to The Regents a written progress report covering Licensee's (and
any Affiliate's or sublicensee's) activities related to the development and
testing of Licensed Products and the obtaining of the governmental approvals
necessary for marketing. Progress reports are required until the first
commercial sale of a Licensed Product occurs in the U.S. and shall be again
required if commercial sales of all Licensed Products are suspended or
discontinued. All reports under this Article 7 shall be deemed the Confidential
Information of Licensee pursuant to the terms of Article 28 (Secrecy).

                                       12
<PAGE>
     8.2  Progress reports submitted under Paragraph 8.1 shall include, but are
not limited to, the following topics:

          8.2.1  a statement specifically addressing each diligence requirement
                 of Article 7 (DUE DILIGENCE),

          8.2.2  summary of work completed,

          8.2.3  key scientific discoveries;

          8.2.4  summary of work in progress,

          8.2.5  current schedule of anticipated events or milestones,

          8.2.6  market plans for introduction of Licensed Product, and

          8.2.7  a summary of resources (dollar value) spent in the reporting
                 period.

     8.3  Licensee has a continuing responsibility to keep The Regents informed
of the large or small business entity status (as defined by the U.S. Patent and
Trademark Office) of itself and its sublicensees and Affiliates.

     8.4  Licensee shall report to The Regents in its immediately subsequent
progress and royalty report the date of first commercial sale of a Licensed
Product in each country.

     8.5    After the first commercial sale of a Licensed Product anywhere in
the world, Licensee shall make quarterly royalty reports to The Regents on or
before each February 28 (for the quarter ending December 31) May 31 (for the
quarter ending March 31), August 31 (for the quarter ending June 30) and
November 30 (for the quarter ending September 30) of each year. Each royalty
report will cover Licensee's most recently completed calendar quarter and will
show:

     8.5.1  the gross sales and Net Sales of Licensed Product sold during the
most recently completed calendar quarter;

     8.5.2  the number of each type of Licensed Product sold;

     8.5.3  the royalties, in U.S. dollars, payable with respect to sales of
Licensed Product;

     8.5.4  the method used to calculate the royalty;

     8.5.5  the exchange rates used;

     8.5.6  a justification in writing for the values of A and B along with the
method of their calculation if combination products are sold and Licensee wishes
to apply the fraction [*** Redacted] as discussed in Paragraph 1.4 "Net Sales";
and

     8.5.7  written evidence of license agreements with third parties that
include the third parties' agreement to a proportional reduction in royalties
due, evidence of payments made to such third

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       13
<PAGE>
parties under such license agreements, and the method of calculation of the
reduced royalty rate if Licensee wishes to implement a reduction in royalties
due under Paragraph 6.2.

     8.6  If no sales of Licensed Product have been made during any reporting
period, then a statement to this effect is required.

9.   BOOKS AND RECORDS

     9.1  Licensee shall keep accurate books and records showing all Licensed
Product manufactured, used and/or sold under the terms of this Agreement. Books
and records must be preserved for at least five (5) years from the date of the
royalty payment to which they pertain.

     9.2  Books and records pertaining to this Agreement must be open to
inspection by representatives or agents of The Regents at reasonable times, no
more than once in any twelve (12) month period and under reasonable conditions
of confidentiality. The Regents shall bear the fees and expenses of examination
but if it is discovered in any examination that Licensee has underpaid by more
than five percent (5%) the royalties due for any year, then Licensee shall bear
the fees and expenses of that examination.

10.  LIFE OF THE AGREEMENT

     10.1 Unless otherwise terminated by operation of law or by acts of the
parties in accordance with the terms of this Agreement, this Agreement will be
in force from the Effective Date until the date of expiration of the
last-to-expire patent licensed under this Agreement; or until the last patent
application licensed under this Agreement is abandoned and no patent in
Regents' Patent Rights ever issues.

     10.2 Any termination of this Agreement will not affect the rights and
obligations set forth in the following Articles:

               Article 9           Books and Records

               Article 13          Disposition of Licensed Product on Hand Upon
                                   Termination

               Article 14          Use of Names and Trademarks

               Article 19          Indemnification

               Article 23          Failure to Perform

               Article 28          Secrecy

                                       14
<PAGE>
11.  TERMINATION BY THE REGENTS

     If Licensee materially breaches this Agreement, then The Regents may give
written notice of default ("Notice of Default") to Licensee. If Licensee fails
to cure the breach within ninety (90) days of the effective date of Notice of
Default, then The Regents may terminate this Agreement and its licenses by a
second written notice ("Notice of Termination"); provided that if Licensee in
good faith disputes The Regents' right to terminate this Agreement during the
foregoing ninety (90) day period, then termination of this Agreement shall not
become effective unless and until (i) the parties have met and attempted to
resolve their dispute by good faith negotiations for at least a period of ninety
(90) days after the Notice of Termination (the "Resolution Period"), and are
unable to do so, and (ii) in the event Licensee files a legal action prior to
the end of the Resolution Period challenging such termination, unless and until
it has been finally determined by a court of competent jurisdiction that The
Regents has the right to terminate this Agreement due to a material breach by
License, and Licensee fails to perform its obligations within ninety (90) days
after such determination. Such termination will not relieve Licensee of its
obligation to pay any fees owing at the time of termination and will not impair
any accrued right of The Regents. These notices are subject to Article 20
(Notices).

12.  TERMINATION BY LICENSEE

     12.1  Licensee has the right at any time to terminate this Agreement in
whole or as to any portion of Regents' Patent Rights by giving notice in writing
to The Regents. Such notice of termination will be subject to Article 20
(Notices) and termination of this Agreement will be effective sixty (60) days
from the effective date of such notice.

     12.2  Any termination under the above Paragraph 13.1 does not relieve
Licensee of any obligation or liability accrued under this Agreement prior to
termination or rescind any payment made to The Regents or anything done by
Licensee prior to the time termination becomes effective. Termination does not
affect in any manner any rights of The Regents arising under this Agreement
prior to termination.

13.  DISPOSITION OF LICENSED PRODUCT ON HAND UPON TERMINATION

     Upon termination of this Agreement, Licensee is entitled to dispose of all
previously made or partially made Licensed Product, but no more, within a
period of one hundred and twenty (120) days

                                       15
<PAGE>
provided that the sale of Licensed Product is subject to the terms of this
Agreement, including, but not limited to, the rendering of reports and payment
of royalties required under this Agreement.

14.  USE OF NAMES AND TRADEMARKS

     14.1  Nothing contained in this Agreement confers any right to use in
advertising, publicity or other promotional activities any name, trade name,
trademark or other designation of either party hereto (including contraction,
abbreviation or simulation of any of the foregoing). Unless required by law, the
use by Licensee of the name "The Regents of the University of California" or the
name of any campus of the University of California is prohibited.

     14.2  The Regents is free to release to the inventors and senior
administrators employed by The Regents the terms and conditions of this
Agreement. If such release is made, then The Regents shall give notice of the
confidential nature and shall request that the recipient does not disclose such
terms and conditions to others. If a third party inquires whether a license to
Regents' Patent Rights is available, then The Regents may disclose the existence
of this Agreement and the extent of the grant in Article 2 (Life of Patent
Exclusive Grant) to such third party, but will not disclose the name of Licensee
or any other terms or conditions of this Agreement, except where The Regents is
required to release information under either the California Public Records Act,
a governmental audit requirement or other applicable law. Licensee may disclose
this Agreement to its advisors, actual or potential investors or business or
acquisition partners, and others on a need-to-know basis under reasonable
conditions of confidentiality.

15.  LIMITED WARRANTY

     15.1  The Regents warrants to Licensee that it has the lawful right to
grant this license.

     15.2  This license and the associated Invention are provided WITHOUT
WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR ANY OTHER
WARRANTY, EXPRESS OR IMPLIED. THE REGENTS MAKES NO REPRESENTATION OR WARRANTY
THAT LICENSED PRODUCT OR LICENSED METHOD WILL NOT INFRINGE ANY PATENT OR OTHER
PROPRIETARY RIGHT.

     15.3  IN NO EVENT SHALL THE REGENTS OR LICENSEE BE LIABLE FOR ANY
INCIDENTAL, SPECIAL, INDIRECT, EXEMPLARY, PUNITIVE OR CONSEQUENTIAL DAMAGES
(INCLUDING LOST PROFITS OR REVENUES) RESULTING FROM EXERCISE OF THIS LICENSE OR
THE USE OF THE INVENTION OR LICENSED PRODUCT OR

                                       16
<PAGE>
OTHERWISE FROM THIS AGREEMENT, WHETHER IN CONTRACT, WARRANTY, TORT, STRICT
LIABILITY OR OTHERWISE, EXCEPT TO THE EXTENT LICENSEE MAY BE REQUIRED TO
INDEMNIFY THE REGENTS FROM SUCH DAMAGES CLAIMED BY THIRD PARTIES UNDER ARTICLE
19, AND EXCEPT FOR AN INTENTIONAL BREACH OF ARTICLE 28.

     15.4  This Agreement does not:

           15.4.1 express or imply a warranty or representation as to the
                  validity or scope of any of Regents' Patent Rights;

           15.4.2 express or imply a warranty or representation that anything
                  made, used, sold, offered for sale or imported or otherwise
                  disposed of under any license granted in this Agreement is or
                  will be free from infringement of patents of third parties;

           15.4.3 obligate The Regents to bring or prosecute actions or suits
                  against third parties for patent infringement except as
                  provided in Article 18 (Patent Infringement);

           15.4.4 confer by implication, estoppel or otherwise any license or
                  rights under any patents of The Regents other than Regents'
                  Patent Rights as defined in this Agreement, regardless of
                  whether those patents are dominant or subordinate to Regents'
                  Patent Rights; or

           15.4.5 obligate The Regents to furnish any know-how not provided in
                  Regents' Patent Rights.

16.  PATENT PROSECUTION AND MAINTENANCE

     16.1  As long as Licensee has paid patent costs as provided for in this
Article 17 (Patent Prosecution and Maintenance), The Regents shall diligently
endeavor to prosecute and maintain the U.S. and foreign patents comprising
Regents' Patent Rights using counsel of its choice, and The Regents shall
provide Licensee in advance (sufficient to provide Licensee with a reasonable
opportunity to review and comment prior to submission thereof) with drafts and
copies of all relevant documentation so that Licensee may be informed of the
continuing prosecution, and Licensee agrees to keep the documentation
confidential pursuant to Article 28 (Secrecy). The Regents' counsel will take
instructions only from The Regents, and all patents and patent applications
under this Agreement will be assigned solely to The Regents.

                                       17
<PAGE>
     16.2 The Regents shall use reasonable efforts to include, or amend to
include, in any patent application claims reasonably requested by Licensee to
protect the products contemplated to be sold under this Agreement, and to
otherwise reasonably consider any comments with respect to the prosecution of
Regents' Patent Rights provided by Licensee.

     16.3 Licensee shall bear the out-of-pocket costs of preparing, filing,
prosecuting and maintaining all U.S. and foreign patent applications within
Regents' Patent Rights contemplated by this Agreement. Costs billed by The
Regents' counsel will be rebilled to Licensee and are due within thirty (30)
days of rebilling by The Regents. These costs include patent prosecution costs
for the Invention incurred by The Regents prior to the execution of this
Agreement and any patent prosecution costs that may be incurred for
patentability opinions, re-examination, re-issue, interferences or inventorship
determinations. Prior prosecution costs will be due upon execution of this
Agreement and billing by The Regents. The Regents acknowledge that certain
prosecution costs have already been paid by Licensee pursuant to the parties'
Letter of Intent, dated September 13, 2001.

     16.4 Licensee may request The Regents to obtain patent protection on the
Invention in foreign countries if available and if it so desires. Licensee shall
notify The Regents of its decision to obtain or maintain foreign patents not
less than sixty (60) days prior to the deadline for any payment, filing or
action to be taken in connection therewith. This notice concerning foreign
filing must be in writing, must identify the countries desired and must reaffirm
Licensee's obligation to underwrite the costs thereof. The absence of such a
notice from Licensee to The Regents will be considered an election not to obtain
or maintain foreign rights.

     16.5 Licensee's obligation to underwrite and to pay patent prosecution
costs will continue for so long as this Agreement remains in effect, but
Licensee may terminate its obligations with respect to any given patent
application or patent upon three (3) months written notice to The Regents. The
Regents will use its best efforts to curtail patent costs when a notice of
termination is received from Licensee. The Regents may prosecute and maintain
such application(s) or patent(s) at its sole discretion and expense, but
Licensee will have no further right or licenses thereunder. Nonpayment of patent
costs may be deemed by The Regents as an election by Licensee not to maintain
application(s) or patent(s); provided that The Regents' notify Licensee of such
nonpayment and its intent to deem Licensee to have made such election, and
Licensee does not make the required payment within thirty (30) days thereafter.

                                       18
<PAGE>
     16.6  The Regents may file, prosecute or maintain patent applications at
its own expense in any country in which Licensee has not elected to file,
prosecute or maintain patent applications in accordance with this Article 16
(Patent Prosecution and Maintenance) and those applications and resultant
patents will not be subject to this Agreement.

17.  PATENT MARKING

     Licensee shall mark all Licensed Product made, used or sold under the terms
of this Agreement, or their containers, in accordance with the applicable patent
marking laws.

18.  PATENT INFRINGEMENT

     18.1  If Licensee learns of the substantial infringement of any patent
licensed under this Agreement, then Licensee shall call The Regents' attention
thereto in writing and provide The Regents with reasonable evidence of
infringement of which Licensee is aware. Neither party will notify a third party
of the infringement of any of Regents' Patent Rights without first obtaining
consent of the other party, which consent will not be unreasonably denied. Both
parties shall use their best efforts in cooperation with each other to terminate
infringement without litigation. It is understood that nothing in this Article
18 shall obligate the Licensee to sublicense any third party.

     18.2  Licensee may request that The Regents take legal action against the
infringement of Regents' Patent Rights. Such request must be in writing and must
include reasonable evidence of infringement and damages to Licensee. If the
infringing activity has not abated within ninety (90) days following the
effective date of request, then The Regents has the right to:

           18.2.1 commence suit on its own account; or

           18.2.2 refuse to participate in the suit, and

     The Regents shall give notice of its election in writing to Licensee by the
end of the one-hundredth (100th) day after receiving notice of written request
from Licensee. Licensee may thereafter bring suit for patent infringement, at
its own expense, if and only if The Regents elects not to commence suit, or does
not respond to Licensee within such 100 day period, and if the infringement
occurred during the period and in a jurisdiction and field of use where Licensee
had exclusive rights under this Agreement apart from the license to the
government hereunder. If, however, Licensee elects to bring suit in accordance
with this Paragraph 19.2, then The Regents may thereafter join that suit at its
own expense. Licensee agrees not to bring suit for patent infringement without
following the procedures of this Paragraph, and both parties agree to be bound
by an order

                                       19
<PAGE>
of a court for patent infringement, patent infringement issues and patent
infringement defenses raised through the pendency of such a suit under this
Paragraph 19.2.

     18.3  Legal action, as is decided on, will be at the expense of the party
bringing suit and all damages recovered thereby will belong to the party
bringing suit, but legal action brought jointly by The Regents and Licensee and
fully participated in by both will be at the joint expense of the parties and
all recoveries will be shared jointly by them in proportion to the share of
expense paid by each party. If The Regents brings suit solely in their own name
without participation by Licensee, then Licensee shall have the option, up to
six (6) months after the filing of the suit, to pay one half (1/2) of The
Regents' attorneys fees and all costs, including internal costs, directly
related to the suit and share equally with The Regents' in The Regents'
recoveries attributable to a period and jurisdiction in which Licensee's rights
are exclusive. The Regents shall keep Licensee informed of its internal costs
directly related to the suit and its accounting thereof from time to time as
requested by Licensee.

      18.4  Each party shall cooperate with the other (including participate,
but only to the extent necessary) in litigation proceedings instituted hereunder
at the expense of the party bringing suit. Litigation will be controlled by the
party bringing the suit, except that The Regents may be represented by counsel
of its choice in any suit brought by Licensee.

19.   INDEMNIFICATION

      19.1  Licensee shall indemnify, hold harmless and defend The Regents, its
officers, employees and agents, the sponsors of the research that led to the
Invention, in their role as sponsors, and the inventors of the patents and
patent applications in Regents' Patent Rights and their employers, in their role
as investors and employers thereof, against any and all third party claims,
suits, losses, liabilities, damages, costs, fees and expenses ("Claims")
resulting from or arising out of exercise of this license or any sublicense,
except to the extent resulting solely from willful misconduct or a breach of
this Agreement by The Regents; provided that Licensee is promptly notified in
writing of such Claims, has sole control of the defense and settlement thereof,
and obtains full cooperation and information from the indemnitee. Licensee shall
have no obligation for fees, costs or expenses incurred without Licensee's prior
written consent, not unreasonably withheld. It is understood that only The
Regents may claim indemnity under Article 19 (on its own behalf or on behalf of
the other above listed indemnitees), and other above listed indemnitees may not
directly

                                       20
<PAGE>
claim indemnity hereunder. This indemnification includes, but is not limited
to, any product liability.

     19.2 Licensee, at its sole cost and expense, shall insure its activities
in connection with the work under this Agreement and obtain, keep in force and
maintain insurance as follows or an equivalent program of self-insurance.

     19.3 Comprehensive or commercial form general liability insurance
(contractual liability included ) with limits as follows:

                         -    Each Occurrence $[*** Redacted]

                         -    Products/Completed Operations Aggregate $[***
                              Redacted]

                         -    Personal and Advertising Injury $[*** Redacted]

                         -    General Aggregate (commercial form only)
                              $[*** Redacted]

     The coverage and limits referred to under the above do not in any way limit
the liability of Licensee. Licensee shall furnish The Regents with certificates
of insurance showing compliance with all requirements. Certificates must:

                         -    Provide for thirty (30) days' advance written
                              notice to The Regents of any modification.

                         -    Indicate that The Regents has been endorsed as an
                              additional Insured under the coverage referred to
                              under the above.

                         -    Include a provision that the coverage will be
                              primary and will not participate with nor will be
                              excess over any valid and collectable insurance or
                              program of self-insurance carried or maintained by
                              The Regents.

     19.4 The Regents shall notify Licensee in writing of any claim or suit
brought against The Regents in respect of which The Regents intends to invoke
the provisions of this Article 19 (Indemnification). Licensee shall keep The
Regents informed on a current basis of its defense of any claims under this
Article 20 (Indemnification).

20.  NOTICES

     20.1 Any notice or payment required to be given to either party shall be
deemed to have been properly given and to be effective as of the date specified
below if delivered to the respective address given below or to another address
as designated by written notice given to the other party:

     20.1.1    on the date of delivery if delivered in person;

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                       21
<PAGE>
     20.1.2 on the date of mailing if mailed by first-class certified mail,
postage paid; or

     20.1.3 on the date of mailing if mailed by any global express carrier
service that requires recipient to sign the documents demonstrating the
delivery of such notice or payment.

     In the case of Licensee:        Nanosys, Inc.
                                     2625 Hanover St.
                                     Palo Alto, CA 94304
                                     Attention: President

     with a copy to:                 Wilson, Sonsini, Goodrich & Rosati
                                     650 Page Mill Road
                                     Palo Alto, California 94304
                                     Attention: Michael J. O'Donnell, Esq.

     In the case of The Regents:     The Regents of the University of California
                                     Office of Technology Transfer
                                     1111 Franklin Street, 5th Floor
                                     Oakland, CA 94607-5200
                                     Attention:   Executive Director
                                                  Research Administration and
                                                  Technology Transfer
                                     RE:   UC Case No. 2001-190

21.  ASSIGNABILITY

     This Agreement may be assigned by The Regents, but is personal to Licensee
and assignable by Licensee only with the written consent of The Regents, which
consent will not be unreasonably withheld; provided, however, that Licensee
shall be entitled to assign this Agreement and all rights hereunder, upon
notice but without the consent of The Regents, in connection with a merger,
consolidation, sale or transfer of all or substantially all of the Licensee's
assets or business pertaining hereto, or its equity.

                                       22
<PAGE>
22.  NO WAIVER

     No waiver by either party of any default of this Agreement may be deemed a
waiver of any subsequent or similar default. A suspension of duty under this
Agreement due to force majeure shall not be for a period longer than one (1)
year.

23.  FAILURE TO PERFORM

     If either party finds it necessary to undertake legal action against the
other on account of failure of performance due under this Agreement, then the
prevailing party is entitled to reasonable attorney's fees in addition to costs
and necessary disbursements.

24.  GOVERNING LAWS

     THIS AGREEMENT WILL BE INTERPRETED AND CONSTRUED IN ACCORDANCE WITH THE
LAWS OF THE STATE OF CALIFORNIA WITHOUT REGARD TO CONFLICT OF LAWS OR TO WHICH
PARTY DRAFTED PARTICULAR PROVISIONS OF THIS AGREEMENT, but the scope and
validity of any patent or patent application will be governed by the
applicable laws of the country of the patent or patent application. Disputes
between the parties regarding this Agreement will utilize only trial courts
within California for disputes that go to court.

25.  PREFERENCE FOR U.S. INDUSTRY

     Because this Agreement grants the exclusive right to use or sell the
Invention in the U.S., Licensee agrees that any products sold in the U.S.
embodying this Invention or produced through the use thereof will be
manufactured substantially in the U.S., to the extent required by law.

26.  GOVERNMENT APPROVAL OR REGISTRATION

     Licensee shall notify The Regents if it becomes aware that this Agreement
is subject to any U.S. or foreign government reporting or approval requirement.
Licensee shall make all necessary filings and pay all costs including fees,
penalties and all other out-of-pocket costs associated with such reporting or
approval process.

27.  EXPORT CONTROL LAWS

     Licensee shall observe all applicable U.S. and foreign laws with respect
to the transfer of Licensed Product and related technical data to foreign
countries, including, without limitation, the International Traffic in Arms
Regulations (ITAR) and the Export Administration Regulations.

                                       23
<PAGE>
28.  SECRECY

     28.1  With regard to confidential information, which can be oral or written
or both, received hereunder by either party from the other party, which are
marked "Confidential" if disclosed in written or other tangible form, or
designated as confidential at the time of first disclosure and confirmed in a
written notice provided within thirty (30) days thereafter, if disclosed orally
(the "Confidential Information"), each party agrees:

          28.1.1  not to use the Confidential Information of the other party
                  except for the sole purpose of performing or exercising rights
                  under the terms of this Agreement;

          28.1.2  to safeguard the Confidential Information of the other party
                  against disclosure to others with the same degree of care as
                  it exercises with its own data of a similar nature, but in no
                  event less than reasonable care;

          28.1.3  not to disclose the Confidential Information of the other
                  party to third parties (except to its employees, agents or
                  consultants who are bound by a like obligation of
                  confidentiality) without the express written permission of the
                  other party

28.2  Notwithstanding the foregoing, Confidential Information shall not include
any information that the receiving party can demonstrate:

          28.2.1  was previously known to it;

          28.2.2  is now or becomes in the future, public knowledge other than
                  through acts or omissions of the receiving party; or

          28.2.3  is lawfully obtained by the receiving party from sources
                  independent of the other party, and without restrictions on
                  its use;

          28.2.4  was independently developed by the receiving party, without
                  use of or reference to the Confidential Information of the
                  other party; or

          28.2.5  is required to be disclosed by law; provided that the
                  receiving party promptly notifies the disclosing party and
                  removes the actual trade secrets of the disclosing party upon
                  request.

28.3  The secrecy obligations of Licensee and The Regents with respect to the
Confidential Information will continue for a period ending five (5) years from
the termination date of this Agreement.

                                       24
<PAGE>
29.  MISCELLANEOUS

     29.1 The headings of the several sections are inserted for convenience of
reference only and are not intended to be a part of or to affect the meaning or
interpretation of this Agreement.

     29.2 This Agreement is not binding on the parties until it has been signed
below on behalf of each party. It is then effective as of the Effective Date.

     29.3 No amendment or modification of this Agreement is valid or binding on
the parties unless made in writing and signed on behalf of each party.

     29.4 This Agreement embodies the entire understanding of the parties and
supersedes all previous communications, representations or understandings,
either oral or written, between the parties relating to the subject matter
hereof. The Letter of Intent (UC Control No. 2002-30-0126) dated September 13,
2001 and its extension and the Secrecy Agreement (UC Control No. 2002-20-0444
effective February 8, 2002 are hereby terminated.

     29.5 In case any of the provisions contained in this Agreement is held to
be invalid, illegal or unenforceable in any respect, that invalidity, illegality
or unenforceability will not affect any other provisions of this Agreement and
this Agreement will be construed as if the invalid, illegal or unenforceable
provisions had never been contained in it.

     29.6 None of the provisions of this Agreement is intended to create any
form of joint venture between the parties, rights in third parties or rights
that are enforceable by any third party.

     IN WITNESS WHEREOF, both The Regents and Licensee have executed this
Agreement, in duplicate originals, by their respective and duly authorized
officers on the day and year written.

NANOSYS, INC.                           THE REGENTS OF THE UNIVERSITY OF
                                        CALIFORNIA

By: /s/ Lawrence A. Bock                By: /s/ Alan B. Bennett
    ---------------------------------       -----------------------------------
              (Signature)                              (Signature)

Name: Lawrence A. Bock                  Name: Alan B. Bennett
      -------------------------------
             (Please Print)

Title: PRESIDENT AND CEO                Title: Executive Director
       ------------------------------          Research Administration and
                                               Technology Transfer

Date: 06-10-02                          Dated: June 17, 2002
      -------------------------------          --------------------------------

Approved as to legal form: /s/ Sandra S. Schultz        6/29/02
                           ------------------------  -------------
                           Sandra S. Schultz         Date
                           University Counsel
                           Office of General Counsel

                                       25<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                   EXHIBIT 10.18

<TABLE>
<S>                                       <C>                                                   <C>                    <C>     <C>
------------------------------------------------------------------------------------------------------------------------------------
                                          1. THIS CONTRACT 18 A RATED ORDER                     RATING                 PAGE of PAGES
AWARD / CONTRACT                          UNDER DPAS (15 CFR 350)              -                    DO-A1                1       17
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                       <C>                  <C>
2. CONTRACT (PROC. INST. IDENT.) NO.      3. EFFECTIVE DATE    4. REQUISITION/PURCHASE REQUEST/PROJECT NO.
            FA8650-04-C-6473                                                            See Section G
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                       <C>                  <C>                                                     <C>
5. ISSUED BY PKH                          CODE  FA8650         6. ADMINISTERED BY (IF OTHER THAN ITEM 5)               CODE   S0507A
                                                ------                                                                        ------
USAF/AFMC                                                      DCMA NORTHERN CALIFORNIA
DET 1 AF RESEARCH LABORATORY                                   P.O. BOX 232
2310 EIGHTH STREET, BUILDING 167                               700 E ROTH ROAD, BLDG. 330 (LATHRO
WRIGHT-PATTERSON AFB OH 45433-7801                             FRENCH CAMP CA 95231-0232
KRISTINA J. CROAKE (937)656-6274                               DCM-SFEXECTEAM@DCMA.MIL
kristina.croake@woafb.af.mil
                                                               SCD: C      PAS: (NONE)
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                       <C>    <C>                              <C>                                  <C>     <C>
7. NAME AND ADDRESS OF CONTRACTOR (NO., STREET, CITY, COUNTY, STATE AND ZIP CODE) 8. DELIVERY
NANOSYS INC                                                                          [ ] FOR Origin  [X] Other (see below)
                                                                                  ----------------------------------------
2625 HANOVER ST                                     MAILED                        9. DISCOUNT FOR PROMPT PAYMENT
PALO ALTO CA 94304-1118                           JUN 30 2004                     N
(650)331-2106
------------------------------------------------------------------------------------------------------------------------------------
                                                                                  10. SUBMIT INVOICES                    ITEM
                                                                                  (4 COPIES UNLESS OTHERWISE
                                                                                  SPECIFIED) TO                            See Block
CAGE CODE 3MVR5                                  FACILITY CODE                    THE ADDRESS SHOWN IN -                      12
------------------------------------------------------------------------------------------------------------------------------------
11. SHIP TO/MARK FOR                      CODE                 12. PAYMENT WILL BE MADE BY                             CODE   HQ0339
                                                                                                                              ------
See Section F                                                  DFAS COLUMBUS CENTER
                                                               DFAS-CO/WEST ENTITLEMENT OPS
                                                               P.O. BOX 182381
                                                               COLUMBUS OH 43218-2381

                                                               EFT: T
------------------------------------------------------------------------------------------------------------------------------------
13. AUTHORITY FOR OTHER THAN FULL AND OPEN COMPETITION         14. ACCOUNTING AND APPROPRIATION DATA
                                                               See Section G
</TABLE>

<TABLE>
<S>                             <C>                            <C>                                  <C>
15A. ITEM NO                    15B. SUPPLIES/SERVICES         15C. QUANTITY 15D. UNIT 15E. UNIT PRICE 15F. AMOUNT
See Section B
------------------------------------------------------------------------------------------------------------------
                                                               15G. TOTAL AMOUNT OF CONTRACT -      $ 2,228,445.00
------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<CAPTION>
                                                16. Table of Contents
------------------------------------------------------------------------------------------------------------------------------------
       SEC             DESCRIPTION                    PAGE(S)          SEC                    DESCRIPTION                   PAGE(S)
------------------------------------------------------------------------------------------------------------------------------------
<S>    <C>   <C>                                      <C>       <C>    <C>     <C>                                          <C>
                  PART I - THE SCHEDULE                                               PART II - CONTRACT CLAUSES
------------------------------------------------------------------------------------------------------------------------------------
-       A    SOLICITATION/CONTRACT FORM                   1     -       I         CONTRACT CLAUSES                             13
------------------------------------------------------------------------------------------------------------------------------------
-       B    SUPPLIES OR SERVICES AND PRICES/COSTS        2                    PART III - LIST OF DOCUMENTS, EXHIBITS & ATTACHMENTS
------------------------------------------------------------------------------------------------------------------------------------
-       C    DESCRIPTION/SPECS./WORK STATEMENT            4     -       J         LIST OF ATTACHMENTS                          17
------------------------------------------------------------------------------------------------------------------------------------
-       D    PACKAGING AND MARKING                        5                     PART IV - REPRESENTATIONS AND INSTRUCTIONS
------------------------------------------------------------------------------------------------------------------------------------
-       E    INSPECTION AND ACCEPTANCE                    6              K       REPRESENTATIONS, CERTIFICATIONS
-------------------------------------------------------------
-       F    DELIVERIES OR PERFORMANCE                    7                      OTHER STATEMENTS OF OFFERORS
------------------------------------------------------------------------------------------------------------------------------------
-       G    CONTRACT ADMINISTRATION DATA                10              L       INSTRS., CONDS., AND NOTICES TO
------------------------------------------------------------------------------------------------------------------------------------
-       H    SPECIAL CONTRACT REQUIREMENTS               12              M       EVALUATION FACTORS FOR AWARD
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                 <C>                         <C>
                                    CONTRACTING OFFICER WILL COMPLETE ITEM 17 OR 18 AS APPLICABLE
------------------------------------------------------------------------------------------------------------------------------------
17.  [X] CONTRACTOR'S NEGOTIATED AGREEMENT                      16.   [ ] AWARD (Contractor is not raquired to sign this  document).
(Contractor is required to sign this document and return 1      Your offer on solicitation number________ including the addition
copies to issuing office). Contractor agrees to furnish and     or changes made by you which additions or changes set forth in full
deliver all Items or perform all services set forth or          above is hereby accepted as to items listed above and on any
otherwise identified above and on any continuation sheets       continuation sheets. This award consummates the contract which
for the consideration stated herein. The rights and             consists of the following documents: (a) the Government's
obligations of the parties to this contract shall be            solicitation and your offer, and (b) this award/contract. No further
subject to and governed by the following documents:             contractual document is necessary.
(a) this award/contract, (b) the solicitation, if any, and
(c) such provisions, representations, certifications, and
specifications, as are attached or incorporated by reference
herein. (Attachments are listed herein.)
</TABLE>

<TABLE>
<S>                                                             <C>
------------------------------------------------------------------------------------------------------------------------------------
19A. NAME AND TITLE OF SIGNER (TYPE OR PRINT)                   20A. NAME OF CONTRACTING OFFICER
     Calvin Chow, Chief Executive Ofcr                          STEPHEN C. DAVIS
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                       <C>                   <C>                                             <C>
19B. Name of Contractor                   19C. Date Signed      20B. United Sates of Amarica                    20C. Date Signed

    Nanosys, Inc.                              6/30/2004                                                            30 JUN 04

by /s/ Calvin Chow                                              by /s/ Stephen C. Davis
   ------------------------------------------------                -------------------------------------------
(signature of person authorized to sign)                              (signature of Contracting Officer)
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<TABLE>
<S>                                                                                         <C>
NSN 7540-01-152-8069                                                                        STANDARD FORM 26 (Rev 4-85)
Previous Editions unusable                                                                  Prescribed by GSA FAR (48 CFR) 53.214(a)
ConWrite Version 6-1.5                                                                      Created 30 Jun 2004 2:42 PM
</TABLE>
<PAGE>

PART I - THE SCHEDULE
SECTION B - SUPPLIES OR SERVICES AND PRICES/COSTS

<TABLE>
<CAPTION>

                                                                  Qty                         Unit Price
ITEM            SUPPLIES OR SERVICES                           Purch Unit                  Total Item Amount
----            --------------------                           ----------                  -----------------
<S>             <C>                                            <C>                         <C>
0001                                                               1                       $    2,228,445.00
                                                                  Each                     $    2,228,445.00
                Noun:                RESEARCH AND DATA
                ACRN:                9
                NSN:                 N - Not Applicable
                DD1423 is Exhibit:   A
                Contract type:       U - COST PLUS FIXED FEE
                Inspection:          DESTINATION
                Acceptance:          DESTINATION
                FOB:                 DESTINATION
                Descriptive Data:
                Conduct Research entitled "Flexible Nanocomposite Photovoltaics"
                in accordance with Section C, Description/Specifications dated 8
                Apr 2004. Deliver data in accordance with Exhibit A, Contract
                Data Requirements List, DD Form 1423, dated 1 Apr 2004.

000101

                Noun:                Funding Info Only
                ACRN:                AA                        $1,114,108.00
                PR/MIPR:             GWSHE047201159                                        $    1,114,108.00
0002                                                                1                      $            0.00
                                                                   Each                    $            0.00
                Noun:                HARDWARE
                ACRN:                U
                NSN:                 N - Not Applicable
                Contract type:       U - COST PLUS FIXED FEE
                Inspection:          DESTINATION
                Acceptance:          DESTINATION
                FOB:                 DESTINATION
                Descriptive Data:
                Deliver hardware in accordance with Section C
                Description/Specifications entitled, "Flexible Nanocomposite
                Photovoltaics", dated 8 Apr 2004.

0003            OPTION CLIN (service)

                Noun:                OPTION 1
                DD1423 is Exhibit:   A
                Descriptive Data:
                Conduct research entitled "Flexible Nanocomposite Photovoltaics"
                in accordance with Sections 3.2 through 3.2.6 of the
                Contractor's Statement of Work (SOW), Attachment 1 to Section J.
                Deliver data, hardware, software, and related documentation in
                accordance with the SOW and CDRLs, dated 8 Apr 2004 and 1 Apr
                2004, respectively.
 </TABLE>

                                                      SECTION B FA8650-04-C-6473

                                                                    PAGE 2 OF 17
<PAGE>

                                                                   Exhibit 10.18

PART I - THE SCHEDULE
SECTION B - SUPPLIES OR SERVICES AND PRICES/COSTS

NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

B049 OPTIONS (APR 2000)

The Government may require performance of the work required by CLIN(s) 0003. The
Contracting Officer shall provide written notice of intent to exercise this
option to the Contractor on or before 30 days prior to the exercise date. If the
Government exercises this option(s) by 14 Apr 2005 (11 MARO), the Contractor
shall perform at the estimated cost and fee, if applicable, set forth as
follows:

Option 1:
Cost: $[*** Redacted]
Fee:  $[*** Redacted]
Total:$2,250,939,00

B054 IMPLEMENTATION OF LIMITATION OF FUNDS (FEB 2003) (TAILORED)

      (a) The sum allotted to this contract and available for payment of costs
under CLINs 0001-0003 through 31 Dec 04 in accordance with the clause in
Section I entitled "Limitation of Funds" is $ 1,114,000.00.

B058 PAYMENT OF FEE (CPFF) (FEB 2003)

The estimated cost and fee for this contract are shown below. The applicable
fixed fee set forth below may be increased or decreased only by negotiation and
modification of the contract for added or deleted work. As determined by the
contracting officer, it shall be paid as it accrues, in regular installments
based upon the percentage of completion of work (or the expiration of the
agreed-upon period(s) for term contracts).

Estimated Cost $[*** Redacted]
Fee $[*** Redacted]

                                                      SECTION B FA8650-04-C-6473

                                                                    PAGE 3 OF 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION C - DESCRIPTION/SPECS./WORK STATEMENT

NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

C003 INCORPORATED DOCUMENTS/REQUIREMENTS (APR 1998)

Contractor's Statement of Work (SOW), entitled "Flexible Nanocomposite
Photovoltaics", dated 8 Apr 2004, Attachment 1 to Section J

                                                      SECTION C FA8650-04-C-6473

                                                                    PAGE 4 OF 17

<PAGE>

PART I - THE SCHEDULE
SECTION D - PACKAGING AND MARKING

NO CLAUSES OR PROVISIONS IN THIS SECTION

                                                      SECTION D FA8650-04-C-6473
                                                                    PAGE 5 OF 17

<PAGE>

PART I - THE SCHEDULE
SECTION E - INSPECTION AND ACCEPTANCE

I. NOTICE: The following contract clauses pertinent to this section are hereby
incorporated by reference:

A. FEDERAL ACQUISITION REGULATION CONTRACT CLAUSES

52.246-08     INSPECTION OF RESEARCH AND DEVELOPMENT -- COST-REIMBURSEMENT (MAY
              2001)

B. DEFENSE FEDERAL ACQUISITION REGULATION SUPPLEMENT CONTRACT CLAUSES

252.246-7000  MATERIAL INSPECTION AND RECEIVING REPORT (MAR 2003)

II. NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

E006 RECEIVING REPORT (DD FORM 250) MAILING ADDRESS (APR 1998)

      (a) Submit original DD Form(s) 250 for all items deliverable under this
contract (e.g. hardware, software, exhibit line items, status reports, services,
etc.) to the following address:

Air Force Research Laboratory, AFRL/HECV
ATTN: Dr. Darrel Hopper
2255 H Street, Building 248
Wright-Patterson AFB OH 45433-7022

      (b) In addition, a copy of the DD Form 250 shall accompany each shipment
for all deliverable items. Shipment addresses are specified in Section F of the
schedule and/or on the Contract Data Requirements List.

      (c) PROCESSING STATUS. Any inquiry as to the processing status of a DD
Form 250 should be made to the following office:

AFRL/HECV

E007 INSPECTION AND ACCEPTANCE AUTHORITY (APR 1998)

Inspection and acceptance for all Contract and Exhibit Lines or Subline Items
shall be accomplished by the Program Manager, Air Force Research Laboratory,
AFRL/HECV, ATTN: [***Redacted], 2255 H Street, Building 248, Wright-Patterson
AFB OH 45433-7022.

                                                      SECTION E FA8650-04-C-6473
                                                                    PAGE 6 OF 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION F - DELIVERIES OR PERFORMANCE

<TABLE>
<CAPTION>
                                             SHIP       MARK       TRANS
ITEM      SUPPLIES SCHEDULE DATA    QTY       TO        FOR         PRI             DATE
----      ----------------------    ---       --        ---         ---             ----
<S>       <C>                       <C>     <C>         <C>        <C>            <C>
0001                                1       FY1456                                12 MARO

          NOUN:                     RESEARCH AND DATA
          ACRN:                     9
          Descriptive Data:
          The scheduled delivery date for the approved final technical report is
          12 months after mailing date. All data shall be delivered in
          accordance with Exhibit A, Contract Data Requirements List, DO Form
          1423, dated 1 Apr 2004. The technical effort must be completed no
          later than ten months after mailing date. Sea F0007 for mailing
          address.

0002                                1       FY1456                                12 MARO

          Noun:                     HARDWARE
          ACRN:                     U
          Descriptive Data:
          The scheduled delivery date for hardware is 12 months after mailing
          date of the contract. The shipping address is: FY1456, Det 1 AFRL/WS,
          Bldg 198, Area B, 2231 Monohan Way, WPAFB, OH 45433-7034, M/F:
          FA8650-04-C-6473, ATTN: [*** Redacted], AFRL/HECV, [*** Redacted].
</TABLE>

                                                      SECTION F FA8650-04-C-6473

                                                                    PAGE 7 OF 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION F - DELIVERIES OR PERFORMANCE

I NOTICE: The following contract clauses pertinent to this section are hereby
incorporated by reference:

FEDERAL ACQUISITION REGULATION CONTRACT CLAUSES

52.242-15       STOP-WORK ORDER (AUG 1989) - ALTERNATE I (APR 1984)
52.247-34       F.O.B. DESTINATION (NOV 1991)

II. NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

F003 CONTRACT DELIVERIES (FEB 1997)

The following terms, if used within this contract in conjunction with contract
delivery requirements (including data deliveries), are hereby defined as
follows:

      (a) "MAC" and "MARO" mean "months after the effective date for award of
the contractual action (as shown in block 3, Section A, SF 26)".

      (b) "WARO" means "weeks after the effective date for award of the
contractual action".

      (c) "DARO" means "days after the effective date for award of the
contractual action".

      (d) "ASREQ" means "as required". Detailed delivery requirements are then
specified elsewhere in Section F.

F005 DELIVERY OF REPORTS (OCT 1998)

      (a) All data shall be delivered in accordance with the delivery schedule
shown on the Contract Data Requirements List, attachments, or as incorporated by
reference.

      (b) All reports and correspondence submitted under this contract shall
include the contract number and project number and be forwarded prepaid. A copy
of the letters of transmittal shall be delivered to the Procuring Contracting
Officer (PCO) and Administrative Contracting Officer (ACO). The addresses are
set forth on the contract award cover page. All other address(es) and code(s)
for consignee(s) are as set forth in the contract or incorporated by reference.

F007 SHIPMENT ADDRESS (SEP 1997)

FY1456
Det 1 AFRL/WS
Building 198, Area B, 2231 Monohan Way
Wright-Patterson AFB, OH 45433-7034

Mark For:

GOVERNMENT PROGRAM MANAGER
ATTN: [***Redacted] (AFRL/HECV)
2255 H Street, Bldg. 248, Room 300
Wright-Patterson AFB OH 45433-7022
[***Redacted]
[***Redacted]

                                                      SECTION F FA8650-04-C-6473

                                                                    PAGE 8 0F 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION F - DELIVERIES OR PERFORMANCE

PROCURING CONTRACTING OFFICER
ATTN: [*** Redacted] (AFRL/PKD)
2310 Eighth Street, Bldg. 167
Wright-Patterson AFB OH 45433-7801
[*** Redacted]
[*** Redacted]

ADMINISTRATIVE CONTRACTING OFFICER
DCMA San Francisco
P.O. Box 232
700 E. Roth Road, Bldg. 330,
French Camp, CA 95231-0232
dcm-sfexecteam@dcma.mil

Defense Advanced Research Projects Agency Program Manager
ATTN: [*** Redacted] (DARPA/MTO)
3701 North Fairfax Drive
Arlington VA 22203-1714
[*** Redacted]
[*** Redacted]

Air Force Research Laboratory
ATTN: [*** Redacted] (AFRL/HEOR)
2610 Seventh Street, Bldg. 441
Wright-Patterson AFB OH 45433-7921
[*** Redacted]
[*** Redacted]

Air Force Research Laboratory
ATTN: [*** Redacted] (AFRL/HEC)
2255 H Street, Bldg. 248
Wright-Patterson AFB OH 45433-7022
[*** Redacted]
[*** Redacted]

Air Force Research Laboratory
ATTN: [*** Redacted] (AFRL/HEF)
2245 Monahan Way, Bldg. 029
Wright-Patterson AFB OH 45433-7008
[*** Redacted]
[*** Redacted]

                                                      SECTION F FA8650-04-C-6473

                                                                    PAGE 9 OF 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION G - CONTRACT ADMINISTRATION DATA

<TABLE>
<CAPTION>
                                                                              Obligation
ACRN          Appropriation/Lmt Subhead/Supplemental Accounting Data            Amount
----          ------------------------------------------------------            ------
<S>           <C>                                                            <C>
AA                                                                           $1,114,108.00

              97  40400 1302 D14 47A8 4H2000 6HCV00 OS836 63739E 503000 F03000
              Funding breakdown:    On CLIN 000101:  $1,114,108.00
              PR/MIPR:              GWSHE047201159   $1,114,108.00
              JON: 71841130
              ARPA Order Number:    S836/00        dated 10 May 2004
              Descriptive data:
              PR COMPLETE
</TABLE>

                                                      SECTION G FA8650-04-C-6473

                                                                   PAGE 10 OF 17

<PAGE>

PART I - THE SCHEDULE
SECTION G - CONTRACT ADMINISTRATION DATA

NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

G002 PROGRAM MANAGER (MAY 1997)

Program Manager: [*** Redacted], [*** Redacted]

G005 PAYMENT INSTRUCTIONS FOR MULTIPLE ACCOUNTING CLASSIFICATION CITATIONS (MAR
2001)

Payment for all effort under this contract should be made in the order and
amounts shown in the informational subline item(s) in Section B, CLIN 0001 of
the contract and recapped below. Exhaust the funds in each ACRN before using
funds from the next listed ACRN.

<TABLE>
<CAPTION>
ACRN                   SUBCLIN NO.                    TOTAL OBLIGATED
<S>                    <C>                            <C>
 AA                      000101                        $1,114,108.00
</TABLE>

      a. This contract will be funded by multiple accounting classification
citations. Payment shall be made from ACRNs in alphabetical order (AA,AB,etc).
DO NOT USE A PRORATED METHOD to pay, disburse and liquidate funds. Do not
liquidate any funds from an ACRN unless the preceding ACRNs have been fully
liquidated, or if revised payment instructions are provided per paragraph b.
below.

      b. Additional ACRNs will be assigned when new accounting classifications
are available. When adding new ACRNs or changing existing ACRNs, the above
payment instructions shall apply, unless specific revised payments instructions
are provided as part of a contract modification.

G006 INVOICE AND PAYMENT - COST REIMBURSEMENT (FEB 1997)

Invoices (or public vouchers), supported by a statement of cost for performance
under this contract, shall be submitted to the cognizant Defense Contract Audit
Agency (DCAA) office. Under the provisions of DFARS 242.803(b), the DCAA
auditor, is designated as the authorized representative of the contracting
officer (CO) for examining vouchers received directly from the contractor.

G014 IMPLEMENTATION OF PATENT RIGHTS CLAUSE (SEP 1999)

All documents and information required by the patent rights and/or patent
reporting clauses set forth in Section I of this contract shall be submitted to
the Administrative Contracting Officer and to the Staff Judge Advocate, AFMC
LO/JAZI, 2240 B Street, Bldg. 11, Room 100, Wright-Patterson AFB OH 45433-7019
or submit via email to afmclo.jaz@wpafb.af.mil. Please include contract number,
followed by the words "Invention Reporting". The AFMC LO/JAZI patent
administrator can be reached at (937) 255-2872. This notice also constitutes a
request (see FAR 52.227-12(f)(10) or DFARS 252.227-7039(c), as applicable) for
submission of a copy of the patent application; when filed, along with the
patent application serial number, filing date, subsequent U.S. patent number and
issue date, as received.

                                                      SECTION G FA8650-04-C-6473

                                                                   PAGE 11 OF 17

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

PART I - THE SCHEDULE
SECTION H - SPECIAL CONTRACT REQUIREMENTS

NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

OTHER CONTRACT CLAUSES IN FULL TEXT

H001 OPTIONS (MAY 1997)

The Government reserves the right to exercise the following option(s) subject to
the stated conditions. In the event an option is exercised, the affected
sections of the contract, e.g., Section B, Section F, Section G, etc., will be
modified as appropriate.

H025 INCORPORATION OF SECTION K (OCT 1998)

Section K of the solicitation is hereby incorporated by reference.

H033 SOLICITATION NUMBER (APR 1998)

Solicitation Number: BAA 03-32

H055 INSURANCE CLAUSE IMPLEMENTATION (FEB 2003)

The Contractor shall obtain and maintain the minimum kinds and amounts of
insurance during performance of this contract as specified by FAR 28.307-2,
Liability, and contemplated by FAR 52.228-5, Insurance--Work on a Government
Installation, and/or 52.228-7, Insurance--Liability to Third Persons.

                                                      SECTION H FA8650-04-C-6473

                                                                   PAGE 12 OF 17
<PAGE>

PART II - CONTRACT CLAUSES
SECTION I - CONTRACT CLAUSES

CONTRACT CLAUSES IN THIS SECTION ARE FROM THE FAR, DEFENSE FAR SUP, AIR FORCE
FAR SUP, AND THE AIR FORCE MATERIEL COMMAND FAR SUP, AND ARE CURRENT THROUGH THE
FOLLOWING UPDATES:

DATABASE_ VERSION: 6.1.x.700; ISSUED: 6/22/2004; FAR: FAC 2001-24 (PARTIAL);
DFAR: DCN20040608; DL.: DL 98-021; CLASS DEVIATIONS: CD 2003o0003; AFFAR: 2002
EDITION; AFMCFAR: AFMCAC 02-04; AFAC: AFAC 2004-0419; IPN: 98-009

I. NOTICE: The following contract clauses pertinent to this section are hereby
incorporated by reference:

A. FEDERAL ACQUISITION REGULATION CONTRACT CLAUSES

<TABLE>
<S>           <C>
52.202-01     DEFINITIONS (DEC 2001)
52.203-03     GRATUITIES (APR 1984)
52.203-05     COVENANT AGAINST CONTINGENT FEES (APR 1984)
52.203-06     RESTRICTIONS ON SUBCONTRACTOR SALES TO THE GOVERNMENT (JUL 1995)
52.203-07     ANTI-KICKBACK PROCEDURES (JUL 1995)
52.203-08     CANCELLATION, RESCISSION, AND RECOVERY OF FUNDS FOR ILLEGAL OR
              IMPROPER ACTIVITY (JAN 1997)
52.203-10     PRICE OR FEE ADJUSTMENT FOR ILLEGAL OR IMPROPER ACTIVITY (JAN 1997)
52.203-12     LIMITATION ON PAYMENTS TO INFLUENCE CERTAIN FEDERAL TRANSACTIONS
              (JUN 2003)
52.204-04     PRINTED OR COPIED DOUBLE-SIDED ON RECYCLED PAPER (AUG 2000)
52.204-07     CENTRAL CONTRACTOR REGISTRATION (OCT 2003)
52.209-06     PROTECTING THE GOVERNMENT'S INTEREST WHEN SUBCONTRACTING WITH
              CONTRACTORS DEBARRED, SUSPENDED, OR PROPOSED FOR DEBARMENT (JUL
              1995)
52.211-05     MATERIAL REQUIREMENTS (AUG 2000)
52.215-02     AUDIT AND RECORDS -- NEGOTIATION (JUN 1999)
52.215-08     ORDER OF PRECEDENCE--UNIFORM CONTRACT FORMAT (OCT 1997)
52.215-11     PRICE REDUCTION FOR DEFECTIVE COST OR PRICING DATA--MODIFICATIONS
              (OCT 1997)
52.215-13     SUBCONTRACTOR COST OR PRICING DATA--MODIFICATIONS (OCT 1997)
52.215-14     INTEGRITY OF UNIT PRICES (OCT 1997)
52.215-15     PENSION ADJUSTMENTS AND ASSET REVERSIONS (JAN 2004)
52.215-18     REVERSION OR ADJUSTMENT OF PLANS FOR POSTRETIREMENT BENEFITS (PRB)
              OTHER THAN PENSIONS (OCT 1997)
52.215-19     NOTIFICATION OF OWNERSHIP CHANGES (OCT 1997)
52.215-21     REQUIREMENTS FOR COST OR PRICING DATA OR INFORMATION OTHER THAN
              COST OR PRICING DATA--MODIFICATIONS (OCT 1997)
52.216-07     ALLOWABLE COST AND PAYMENT (DEC 2002)
52.216-08     FIXED FEE (MAR 1997)
52.219-08     UTILIZATION OF SMALL BUSINESS CONCERNS (MAY 2004)
52.222-01     NOTICE TO THE GOVERNMENT OF LABOR DISPUTES (FEB 1997)
52.222-02     PAYMENT FOR OVERTIME PREMIUMS (JUL 1990)
              Para (a), Dollar amount is '$0.00'
52.222-03     CONVICT LABOR (JUN 2003)
52.222-21     PROHIBITION OF SEGREGATED FACILITIES (FEB 1999)
52.222-26     EQUAL OPPORTUNITY (APR 2002)
52.222-35     EQUAL OPPORTUNITY FOR SPECIAL DISABLED VETERANS, VETERANS OF THE
              VIETNAM ERA, AND OTHER ELIGIBLE VETERANS (DEC 2001)
52.222-36     AFFIRMATIVE ACTION FOR WORKERS WITH DISABILITIES (JUN 1998)
</TABLE>

                                                      SECTION I FA8650-04-C-6473

                                                                  PAGE 13 OF  17

<PAGE>

PART II - CONTRACT CLAUSES
SECTION I - CONTRACT CLAUSES

<TABLE>
<S>           <C>
52.222-37     EMPLOYMENT REPORTS ON SPECIAL DISABLED VETERANS, VETERANS OF THE
              VIETNAM ERA, AND OTHER ELIGIBLE VETERANS (DEC 2001)
52.223-06     DRUG-FREE WORKPLACE (MAY 2001)
52.223-14     TOXIC CHEMICAL RELEASE REPORTING (AUG 2003)
52.225-13     RESTRICTIONS ON CERTAIN FOREIGN PURCHASES (DEC 2003)
52.227-01     AUTHORIZATION AND CONSENT (JUL 1995) - ALTERNATE I (APR 1984)
52.227-02     NOTICE AND ASSISTANCE REGARDING PATENT AND COPYRIGHT INFRINGEMENT
              (AUG 1996)
52.227-11     PATENT RIGHTS -- RETENTION BY THE CONTRACTOR (SHORT FORM) (JUN
              1997) Para (1), Communications: '"The contractor shall forward the
              invention reports called for by the Patents Rights clause through
              the Administrative Contracting Office addressed through AFMC
              LO/JAZI, 2240 B Street, Room 100, Wright-Patterson AFB, OH
              45433-7109. Invention reports may be e-mailed to:
              afmclo.jaz@wpafb.af.mil <mailto:afmclo.jaz@wpafb.af.mil>. Ensure
              e-mail includes your contract number, followed by the words
              "Invention Reporting" on the subject line." "The contractor shall
              forward the invention reports called for by the Patents Rights
              clause through the Administrative Contracting Office addressed
              through AFMC LO/JAZI, 2240 B Street, Room 100, Wright-Patterson
              AFB, OH 45433-7109. Invention reports may be e-mailed to:
              afmclo.jaz@wpafb.af.mil <mailto:afmclo.jaz@wpafb.af.mil>, Ensure
              e-mail includes your Contract number, followed by the words
              "Invention Reporting" on the subject line"'
52.228-07     INSURANCE -- LIABILITY TO THIRD PERSONS (MAR 1996)
52.232-09     LIMITATION ON WITHHOLDING OF PAYMENTS (APR 1984)
52.232-17     INTEREST (JUN 1996)
52.232-22     LIMITATION OF FUNDS (APR 1984)
52.232-23     ASSIGNMENT OF CLAIMS (JAN 1986) -- ALTERNATE I (APR 1984)
52.232-25     PROMPT PAYMENT (OCT 2003)
52.232-33     PAYMENT BY ELECTRONIC FUNDS TRANSFER--CENTRAL CONTRACTOR
              REGISTRATION (OCT 2003)
52.233-01     DISPUTES (JUL 2002)
52.233-03     PROTEST AFTER AWARD (AUG 1996) - ALTERNATE I (JUN 1985)
52,242-01     NOTICE OF INTENT TO DISALLOW COSTS (APR 1984)
52.242-03     PENALTIES FOR UNALLOWABLE COSTS (MAY 2001)
52.242-04     CERTIFICATION OF FINAL INDIRECT COSTS (JAN 1997)
52.242-13     BANKRUPTCY (JUL 1995)
52.243-02     CHANGES -- COST-REIMBURSEMENT (AUG 1987) - ALTERNATE V (APR 1984)
52.243-06     CHANGE ORDER ACCOUNTING (APR 1984)
52.243-07     NOTIFICATION OF CHANGES (APR 1984)
              Para (b), Number of calendar days is (insert 30 for RDSS/C) '30
              days'
              Para (d), Number of calendar days is (insert 30 for RDSS/C) '30
              days'
52.244-02     SUBCONTRACTS (AUG 1998) - ALTERNATE I (AUG 1998)
              Para (e), Contractor shall obtain the Contracting Officer's
              written consent before placing the following subcontracts: 'None'
              Para (k), Insert subcontracts which were evaluated during
              negotiations: 'University of California Berkeley; Battelle
              Memorial Institute, Pacific NW; and Science Applications
              International Corporation (SAIC)'
52.244-05     COMPETITION IN SUBCONTRACTING (DEC 1996)
52.244-06     SUBCONTRACTS FOR COMMERCIAL ITEMS (MAY 2004)
52.245-05     GOVERNMENT PROPERTY (COST-REIMBURSEMENT, TIME-AND-MATERIAL, OR
              LABOR-HOUR CONTRACTS) (DEVIATION) (MAY 2004)
52.246-23     LIMITATION OF LIABILITY (FEB 1997)
52.247-01     COMMERCIAL BILL OF LADING NOTATIONS (APR 1984)
52.247-67     SUBMISSION OF COMMERCIAL TRANSPORTATION BILLS TO THE GENERAL
              SERVICES ADMINISTRATION FOR AUDIT (JUN 1997)
52.249-06     TERMINATION (COST-REIMBURSEMENT) (MAY 2004)
52.249-14     EXCUSABLE DELAYS (APR 1984)
52.253-01     COMPUTER GENERATED FORMS (JAN 1991)
</TABLE>

                                                      SECTION I FA8650-04-C-6473

                                                                   PAGE 14 OF 17

<PAGE>

PART II - CONTRACT CLAUSES
SECTION I - CONTRACT CLAUSES

B. DEFENSE FEDERAL ACQUISITION REGULATION SUPPLEMENT CONTRACT CLAUSES

<TABLE>
<S>             <C>
252.203-7001    PROHIBITION ON PERSONS CONVICTED OF FRAUD OR OTHER DEFENSE-
                CONTRACT-RELATED FELONIES (MAR 1999)
252.204-7003    CONTROL OF GOVERNMENT PERSONNEL WORK PRODUCT (APR 1992)
252.204-7004    ALTERNATE A TO FAR 52.204-7, CENTRAL CONTRACTOR REGISTRATION (NOV
                2003)
252.205-7000    PROVISION OF INFORMATION TO COOPERATIVE AGREEMENT HOLDERS (DEC 1991)
252.209-7000    ACQUISITION FROM SUBCONTRACTORS SUBJECT TO ON-SITE INSPECTION UNDER
                THE INTERMEDIATE-RANGE NUCLEAR FORCES (INF) TREATY (NOV 1995)
252.209-7004    SUBCONTRACTING WITH FIRMS THAT ARE OWNED OR CONTROLLED BY THE
                GOVERNMENT OF A TERRORIST COUNTRY (MAR 1998)
252.215-7000    PRICING ADJUSTMENTS (DEC 1991)
252.225-7004    REPORTING OF CONTRACT PERFORMANCE OUTSIDE THE UNITED STATES (APR
                2003)
252.225-7012    PREFERENCE FOR CERTAIN DOMESTIC COMMODITIES (JUN 2004)
252.225-7014    PREFERENCE FOR DOMESTIC SPECIALTY METALS (APR 2003)
252.225-7025    RESTRICTION ON ACQUISITION OF FORGINGS (APR 2003)
252.225-7030    RESTRICTION ON ACQUISITION OF CARBON, ALLOY, AND ARMOR STEEL PLATE
                (APR 2003)
252,225-7031    SECONDARY ARAB BOYCOTT OF ISRAEL (APR 2003)
252.226-7001    UTILIZATION OF INDIAN ORGANIZATIONS, INDIAN-OWNED ECONOMIC
                ENTERPRISES, AND NATIVE HAWAIIAN SMALL BUSINESS CONCERNS (OCT 2003)
252.227-7013    RIGHTS IN TECHNICAL DATA--NONCOMMERCIAL ITEMS (NOV 1995)
252.227-7014    RIGHTS IN NONCOMMERCIAL COMPUTER SOFTWARE AND NONCOMMERCIAL
                COMPUTER SOFTWARE DOCUMENTATION (JUN 1995)
252.227-7016    RIGHTS IN BID OR PROPOSAL INFORMATION (JUN 1995)
252.227-7019    VALIDATION OF ASSERTED RESTRICTIONS--COMPUTER SOFTWARE (JUN 1995)
252.227-7030    TECHNICAL DATA -- WITHHOLDING OF PAYMENT (MAR 2000)
252.227-7034    PATENTS--SUBCONTRACTS (APR 1984)
252.227-7037    VALIDATION OF RESTRICTIVE MARKINGS ON TECHNICAL DATA (SEP 1999)
252.227-7039    PATENTS--REPORTING OF SUBJECT INVENTIONS (APR 1990)
252.231-7000    SUPPLEMENTAL COST PRINCIPLES (DEC 1991)
252.232-7003    ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (JAN 2004)
252.235-7010    ACKNOWLEDGMENT OF SUPPORT AND DISCLAIMER (MAY 1995)
                Para (a), name of contracting agency(ies): 'United States Air Force'
                Para (a), contract numbers): 'FA8650-04-C-6473'
                Para (b), name of contracting agency(ies): 'United States Air Force'
252.235-7011    FINAL SCIENTIFIC OR TECHNICAL REPORT (SEP 1999)
252.242-7000    POSTAWARD CONFERENCE (DEC 1991)
252.243-7002    REQUESTS FOR EQUITABLE ADJUSTMENT (MAR 1998)
252.244-7000    SUBCONTRACTS FOR COMMERCIAL ITEMS AND COMMERCIAL COMPONENTS (DOD
                CONTRACTS) (MAR 2000)
252.245-7001    REPORTS OF GOVERNMENT PROPERTY (MAY 1994)
252.247-7023    TRANSPORTATION OF SUPPLIES BY SEA (MAY 2002)
252.247-7024    NOTIFICATION OF TRANSPORTATION OF SUPPLIES BY SEA (MAR 2000)
</TABLE>

II. NOTICE: The following contract clauses pertinent to this section are hereby
incorporated in full text:

                                                      SECTION I FA8650-04-C-6473

                                                                   PAGE 15 OF 17

<PAGE>

PART II - CONTRACT CLAUSES
SECTION I - CONTRACT CLAUSES

FEDERAL ACQUISITION REGULATION CONTRACT CLAUSES IN FULL TEXT

52.211-15 DEFENSE PRIORITY AND ALLOCATION REQUIREMENTS (SEP 1990)

This is a rated order certified for national defense use, and the Contractor
shall follow all the requirements of the Defense Priorities and Allocations
System regulation (15 CFR 700).

52.252-02 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force
and effect as if they were given in full text. Upon request, the Contracting
Officer will make their full text available. Also, the full text of a clause may
be accessed electronically at this/these address(es):
http://farsite.hill.af.mil/

52.252-06 AUTHORIZED DEVIATIONS IN CLAUSES (APR 1984)

      (a) The use in this solicitation or contract of any Federal Acquisition
Regulation (48 CFR Chapter 1) clause with an authorized deviation is indicated
by the addition of "(DEVIATION)" after the date of the clause.

      (b) The use in this solicitation or contract of any Defense Federal
Acquisition Regulation Supplement (48 CFR Chapter 2) clause with an authorized
deviation is indicated by the addition of "(DEVIATION)" after the name of the
regulation.

                                                      SECTION I FA8650-04-C-6473

                                                                   PAGE 16 OF 17

<PAGE>

PART III - LIST OF DOCUMENTS, EXHIBITS & ATTACHMENTS
SECTION J - LIST OF ATTACHMENTS

<TABLE>
<CAPTION>
  DOCUMENT       PGS        DATE                         TITLE
------------     ---     -----------    ----------------------------------------
<S>              <C>     <C>            <C>
EXHIBIT A        9       01 APR 2004    CONTRACT DATA REQUIREMENTS LIST (CDRL),
                                        DD FORM 1423-1

ATTACHMENT 1     5       08 APR 2004    "FLEXIBLE NANOCOMPOSITE PHOTOVOLTAICS"

ATTACHMENT 2     4       30 JUN 2004    DFARS 252.227-7017, "IDENTIFICATION AND
                                        ASSERTION OF USE, RELEASE OR DISCLOSURE
                                        RESTRICTIONS (JUN 1995)" AND CONTRACTOR'S
                                        LIST OF TECHNICAL DATA OR COMPUTER
                                        SOFTWARE TO BE DELIVERED WITH
                                        RESTRICTIONS
</TABLE>

                                                      SECTION J FA8650-04-C-6473

                                                                   PAGE 17 OF 17

<PAGE>

      CONTRACT DATA REQUIREMENTS  LIST                  FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010.12-M
          0001                       A        TDP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM             3. SUBTITLE
      A001        SCIENTIFIC AND TECHNICAL REPORTS  Final Report

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-MISC-80711A/T                                    CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12.DATE OF FIRST SUBMISSION     14. DISTRIBUTION
                     REQUIRED                 ONE/R                    **
      XX                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE OF SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
      A                                         *                    ***                                             Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------
16. REMARKS                                                                               AFRL/HECV          2       2       2

Tailored to require the official AFRL and DARPA emblems to be placed in the
upper right hand corner of the front cover with affected entries adjusted as
required (AFRL will supply a copy of the emblem); Block 10, is clarified so
that, "Pursuant to DFARS 252.235-7011, the Government will forward the approved
final report to the Defense Technical Information Center (DTIC) to fulfill the
DTIC submission requirement. The Contractor shall not submit the final report
directly to DTIC."

*   12MAC for Base Effort
    24MAC after option 1 exercised

**  30 days after Block 11 time

Approval/disapproval by letter from the Air Force Program Manager within 60 days
after receipt.

***Disapproval requires correction/resubmission within 30 days after receipt of
Air Force comments.

Draft report shall be unbound, in standard size type, double-spaced and
single-sided.

Reproducibles shall be 1). a CAMERA READY, unbound, suitable for offset
reproduction, and 2). on 3.5" floppy disk (or CD-ROM, or ZIP drive disk)
compatible with MS-Office for Windows, and both shall incorporate all changes
made in the corrected draft. All photos shall be glossy finished. Submit the
reproducible(s) with the final corrected version only.

The contractor is reminded that the National Industrial Security Program
Operating Manual, DOD 5220.22-M, Chapter 4, Paragraph 4-208 (a), dated January
1995 requires that records be maintained when documents derive classified from
multiple sources.

                                                                                          15. TOTAL          2       2       2
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[***Redacted]            22-MAR-04     /s/ [***Redacted]              01-APR-04
AFRL/HECV, [***Redacted]               [***Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 1-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 DATA ITEM)                           OMB No. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations and
Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and
to the Office of Management and Budget, Paperwork Reduction Project (0704-0188),
Washington, DC 20503. Please DO NOT RETURN your form to either of these
addresses. Send completed form to the Government Issuing Contracting Officer for
the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010.12-M
          0001                       A        TOP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM             3. SUBTITLE
      A002        SCIENTIFIC AND TECHNICAL REPORTS  Contractor's Billing Voucher

<TABLE>
<S>               <C>                         <C>                    <C>
4. AUTHORITY (Data Acquisition Document No.)  5. CONTRACT REFERENCE  6. REQUIRING OFFICE
               DI-MISC-80711A/T                        CSOW                AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
      LT             REQUIRED                 MTHLY                   *
                         B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE Of SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
   N/A                                          *                     *                                             Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------
16. REMARKS                                                                               AFRL/HEC           0       1       0
                                                                                          AFRL/HECV          0       1       0
Tailored 1.) to require only a photocopy of the contractor's billing voucher              AFRL/HEF           0       1       0
which is prepared by the contractor to receive payment for this contract's work,          AFRL/PRKA          0       1       0
and 2.) to require the reporting of current Earned, Billed and Paid funds as              DARPA/MTO          0       l       0
defined herein. Block 10 is clarified so that distribution to DTIC shall only be          DCMA/ACO           0       1       0
through Air Force distribution channels.

      Earned means amount of funds earned by the contractor and the suppliers
      or subcontractor's through labor or material purchases.

      Billed means amount of funds that have been billed to the government by
      the contractor.

      Paid means the amount of funds paid by the government to the contractor.

   Submit via e-mail.

 * At the close of the contractor's monthly accounting period.

** 25 days after Block 11 time.

                                                                                          15. TOTAL          0       6       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[***Redacted]            22-MAR-04     [***Redacted]                  01-APR-04
AFRL/HECV, [***Redacted]               [***Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 2-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 Data Item)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of Information. Send comments regarding
this burden estimate or any other aspect of this collection of information
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010,12-M
          0001                       A        TDP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM                  3. SUBTITLE
      A003        FUNDS AND MAN-HOUR EXPENDITURE REPORT

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-FNCL-80331/T                                    CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>            <C>      <C>     <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12.DATE OF FIRST SUBMISSION     14. DISTRIBUTION
                     REQUIRED                 MTHLY                   **
      LT                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE OF SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
    N/A                                         *                     **                                            Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                               AFRL/HEC           0       1       0
Tailored to allow contractor's format                                                     AFRL/HECV          0       1       0
                                                                                          AFRL/HEF           0       1       0
Submit via e-mail.                                                                        AFRL/PRKA          0       1       0
                                                                                          DARPA/MTO          0       l       0
      * At the close of the contractor's monthly accounting period.                       DCMA/ACO           0       1       0

     ** 25 days after Block 11 time.

                                                                                          15. TOTAL          0       6       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted]           22-MAR-04     /s/ [*** Redacted]             01-APR-04
AFRL/HECV, [*** Redacted]              [*** Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 3-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF:  DOD 5010.12-M
          0001                       A        TOP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM                3. SUBTITLE
      A004        CONTRACT FUNDS STATUS REPORT (CFSR)

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-MGMT-81468/T                                    CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
      LT             REQUIRED                 QTRLY                    **
                         B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE OF SUBSEQUENT          a. ADDRESSEE                 Final
     N/A                                        *             SUBMISSION                                   Draft  --------------
                                                                      **                                            Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                               AFRL/HEC           0       1       0

Tailored so that the report contains forecasts by month for the next six months,          AFRL/HECV          0       1       0
by quarter for the remaining fiscal year, and by year for the remaining fiscal            AFRL/HEF           0       1       0
years. CFSR data shall be reconciled to the Government fiscal year end at 30              AFRL/PRKA          0       1       0
September if the contractor's fiscal year end does not coincide with the                  DARPA/MTO          0       l       0
Government's fiscal year end.                                                             DCMA/ACO           0       1       0

Submit via e-mail

   * The last day of the contractor's monthly accounting period nearest the end
of the governments fiscal year quarter.

   ** The initial submission shall be within 25 calendar days after the close of
the contractor's monthly accounting period nearest the end of the first
government fiscal year quarter after contract award. Subsequent submissions
shall be 25 calendar days after Block 11 time.

                                                                                          15. TOTAL          0       6       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted)           22-MAR-04     /s/ [*** Redacted]             01-APR-04
AFRL/HECV, [*** Redacted]              [*** Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 4-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY:
                                                       N/A REF: DOD 5010.12-M
          0001                       A        TOP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM                  3. SUBTITLE
      A005        STATUS REPORTS

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-MGMT-80368/T                                    CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
                     REQUIRED                 MTHLY                    *
      LT                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE Of SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
      N/A                                       *                      *                                            Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                               AFRL/HEC           0       1       0
                                                                                          AFRL/HECV          0       1       0
Tailored to allow contractor's format and to delete Block 10, para 10.2.2.3.              AFRL/HEF           0       1       0
                                                                                          AFRL/PRKA          0       1       0
 Submit via email, except when final report is due to be submitted, then omit             DARPA/MTO          0       l       0
this item.                                                                                DCMA/ACO           0       1       0

      *  At the close of the contractor's monthly accounting period.

      ** 25 days after Block 11 time.

                                                                                          15. TOTAL          0       6       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted]           22-MAR-04     [*** Redacted]                 01-APR-04
AFRL/HECV, [*** Redacted]              [*** Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 5-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                  FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for Information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010, 12-M
          0001                       A        TDP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM                  3. SUBTITLE
      A006        PRESENTATION MATERIAL

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-ADMN-81373/T                                    CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
                     REQUIRED                 ASREQ                    *
      LT                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE OF SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
   N/A                                          *                      *                                            Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                                AFRL/HECV          0       1       1

Tailored to require view graphs and hardcopy or computer generated file.

ASREQ means as required to document topics under discussion at briefings and
reviews.

  * Submit at each briefing or review as appropriate.

Maximum # of view graphs shall not exceed 210 per each quarterly review for this
contract.

Submit reproducible on media compatible with MS-Office for Windows.

                                                                                          15. TOTAL          0       1       1
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted]           22-MAR-04     /s/ [*** Redacted]           01-APR-04
AFRL/HECV, [*** Redacted]              [*** Redacted]
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 6-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010.12-M
          0001                       A        TOP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

<TABLE>
<S>                                                      <C>
1. DATA ITEM NO.  2. TITLE OF DATA ITEM                  3. SUBTITLE
      A007        SCIENTIFIC AND TECHNICAL REPORTS       Technical Management Report
                                                         (TMR)
</TABLE>

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-MISC-80711A/T                                   CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
                     REQUIRED                 QRTLY                    *
      LT                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE Of SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
     N/A                                       N/A                    **                                           Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                               AFRL/HECV          0       1       0

Tailored to allow contractor's format, and Block 10 is clarified so that
distribution to DTIC shall only be through Air Force distribution channels.

* 4MAC and every 90 days thereafter except when final report is due, then omit
this item.

** Every 90 days through out the life of the contract.

Submit via email.

                                                                                          15. TOTAL          0       1       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted]           22-MAR-04     /s/ [*** Redacted]             01-APR-04
AFRL/HECV, [*** Redacted]              [*** Redacted}
                                       Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 7-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

      CONTRACT DATA REQUIREMENTS LIST                   FORM APPROVED
              (1 DATA ITEM)                           OMB NO. 0704-0188

Public reporting burden for this collection of information is estimated to
average 110 hours per response, including the time for reviewing instructions,
searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. Send comments regarding
this burden estimate or any other aspect of this collection of information,
including suggestions for reducing this burden, to Department of Defense,
Washington Headquarters Services, Directorate for information Operations
and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302,
and to the Office of Management and Budget, Paperwork Reduction Project
(0704-0188), Washington, DC 20503. Please DO NOT RETURN your form to either of
these addresses. Send completed form to the Government Issuing Contracting
Officer for the Contract/PR No. listed in Block E.

A. CONTRACT LINE ITEM NO.    B. EXHIBIT    C. CATEGORY: N/A REF: DOD 5010.12-M
          0001                       A        TOP______  TM______  OTHER________

D. SYSTEM/ITEM                 E. CONTRACT/PR NO.            F. CONTRACTOR
             71841130               FA8650-04-C-6473         NANOSYS, INC

1. DATA ITEM NO.  2. TITLE OF DATA ITEM                  3. SUBTITLE
      A008        SCIENTIFIC AND TECHNICAL REPORTS       Hardware Manual

<TABLE>
<S>                                            <C>                        <C>
4. AUTHORITY (Data Acquisition Document No.)   5. CONTRACT REFERENCE      6. REQUIRING OFFICE
               DI-MISC-80711A/T                                   CSOW                  AFRL/HECV
</TABLE>

<TABLE>
<S>               <C>                   <C>               <C>                             <C>
7. DD 250 REQ     9. DIST STATEMENT     10. FREQUENCY     12. DATE OF FIRST SUBMISSION    14. DISTRIBUTION
                     REQUIRED                ONE/R                     **
      LT                 B                                                                                      b. COPIES
                                                                                                         -----------------------
8. APP CODE                             11. AS OF DATE    13. DATE Of SUBSEQUENT          a. ADDRESSEE                 Final
                                                              SUBMISSION                                   Draft  --------------
      A                                         *                    ***                                           Reg    Repro
--------------------------------------------------------------------------------------------------------------------------------

16. REMARKS                                                                               AFRL/HECV          1       1       1
Tailored to allow contractor's format, and Block 10 is clarified so that
distribution to DTIC shall only be through Air Force distribution channels.

* 12MAC for Base Effort
  24MAC after Option 1 exercised

** 30 days after Block 11 time

Approval/disapproval by letter form the Air Force Program Manager within 60 days
after receipt.
*** Disapproval requires correction/resubmission within 30 days after receipt of
Air Force comments.

Submit via email.

Submit reproducible on media compatible with MS-Office for Windows.

                                                                                          15. TOTAL          0       1       0
--------------------------------------------------------------------------------------------------------------------------------
</TABLE>

17. PRICE GROUP

18. ESTIMATED TOTAL PRICE

G. PREPARED BY           H. DATE       I. APPROVED BY                 J. DATE
[*** Redacted]           22-MAR-04     /s/ [*** Redacted]             01-APR-04
AFRL/HECV, [*** Redacted]               [*** Redacted]
                                   Data Manager Det 1 AFRL/WSC

DD FORM 1423-1, JUN 90    Previous editions are obsolete     PAGE 8-A of 8 Pages

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

                     INSTRUCTIONS FOR COMPLETING DD FORM 142
                 (See DoD 5010.12-M for detailed instructions.)

                            FOR GOVERNMENT PERSONNEL

Item A.    Self-explanatory.

Item B.    Self-explanatory.

Item C.    Mark (X) appropriate category: TDP - Technical Data Package;
TM-Technical Manual; Other - other category of data, such as "Provisioning,"
"Configuration Management", etc.

Item D.    Enter name of system/item being acquired that data will support.

Item E.    Self-explanatory (to be filled in after contract award).

Item F.    Self-explanatory (to be filled in after contract award).

Item G.    Signature of preparer of CDRL.

Item H.    Date CDRL was prepared.

Item I.    Signature of CDRL approval authority.

Item J.    Date CDRL was approved.

Item 1.    See DoD FAR Supplement Subpart 4.71 for proper numbering.

Item 2.    Enter title as it appears on data acquisition document cited in

Item 3.    Enter subtitle of data item for further definition of data item
(optional entry).

Item 4.    Enter Data Item Description (DID) number, military specification
number, or military standard number listed in DoD 5010.12-L (AMSDL), or one-time
DID number, that defines data content and formal requirements.

Item 5.    Enter reference to tasking in contract that generates requirement for
the data item (e.g., Statement of Work paragraph number).

Item 6.    Enter technical office responsible for ensuring adequacy of the data
item.

Item 7.    Specify requirement for inspection/acceptance of the data item by the
Government.

Item 8.    Specify requirement for approval of a draft before preparation of the
final data item.

Item 9.    For technical data, specify requirement for contractor to mark the
appropriate distribution statement on the data (ref. DoDD 5230.24).

Item 10.   Specify number of times data items are to be delivered.

Item 11.   Specify as-of-data item, when applicable.

Item 12.   Specify when first submittal is required.

Item 13.   Specify when subsequent submittals are required, when applicable.

Item 14.   Enter addressees and number of draft/final copies to be delivered to
each addressee. Explain reproducible copies in item 16.

Item 15.   Enter total number of draft/final copies to be delivered.

Item 16.   Use for additional/clarifying information for items 1 through 15,
Examples are: Tailoring of documents cited in item 4; Clarification of submittal
dates in items 12 and 13; Explanation of reproducible copies in item 14; Desired
medium for delivery of the data item.

                               FOR THE CONTRACTOR

Item 17.   Specify appropriate price group from one of the following groups of
effort in developing estimated prices for each data item listed on the DD Form
1423.

     a.    Group I. Definition - Data which is not otherwise essential to the
contractor's performance of the primary contracted effort (production,
development, testing, and administration) but which is required by DD Form 1423.

     Estimated Price - Costs to be included under Group I are those applicable
to preparing and assembling the data item in conformance with Government
requirements, and the administration and other expenses related to reproducing
and delivering such data items to the Government.

     b.    Group II. Definition - Data which is essential to the performance of
the primary contracted effort but the contractor is required to perform
additional work to conform to Government requirements with regard to depth of
content, format, frequency of submittal, preparation, control, or quality of the
data item.

     Estimated Price - Costs to be included under Group II are those incurred
over and above the cost of the essential data item without conforming to
Government requirements, and the administrative and other expenses related to
reproducing and delivering such data item to the Government.

     c.    Group III. Definition - Data which the contractor must develop for
his internal use in performance of the primary contracted effort and does not
require any substantial change to conform to Government requirements with regard
to depth of content, format, frequency of submittal, preparation, control, and
quality of the data item.

     Estimated Price - Costs to be included under Group III are the
administrative and other expenses related to reproducing and delivering such
data item to the Government.

     d.    Group IV. Definition - Data which is developed by the contractor as
part of his normal operating procedures and his effort in supplying these data
to the Government is minimal.

     Estimated Price - Group IV items should normally be shown on the DD Form
1423 at no cost.

Item 18.   For each data item, enter an amount equal to that portion of the
total price which is estimated to be attributable to the production or
development for the Government of that item of data. These estimated data prices
shall be developed only from those costs which will be incurred as a direct
result of the requirement to supply the data, over and above those costs which
would otherwise be incurred in performance or the contract if no data were
required. The estimated data prices shall not include any amount for rights of
data. The Government's right to use the data shall be governed by the pertinent
provisions of the contract.

D FORM 1423-1 REVERSE. JUN 90

<PAGE>

FA8650-04-C-6473 (NANOSYS)                                         ATTACHMENT #1

             FLEXIBLE SHAPED-NANOCRYSTAL NANOCOMPOSITE PHOTOVOLTAICS
                                STATEMENT OF WORK
                                  8 APRIL 2004

1. SCOPE

This program is to research, develop, and demonstrate innovative light-weight
low-cost flexible nanostructured devices to efficiently convert solar radiation
into electricity and, thereby, provide power generation solutions for the
warfighter that have not been possible up until now. All materials, methods,
tools and procedures shall be consistent with a generic methodology and not a
point solution for a single application. The program contemplates a four-phase,
60-month development including prototype demonstration of a military-relevant
application. The research shall take place over a period of 12 months for Phase
1 (basic effort) and 12 months for Phase 2 (Option 1 effort). Option exercise
will be based on the achievement of performance goals (defined below in SOW
Section 3, REQUIREMENTS) and the potential for production, insertion, transition
or overall benefit provision to the Department of Defense (DoD).

2. BACKGROUND

Nanoscience has created new materials and structures with novel electro-optical
properties. The time has come to initiate exploratory research to discover how
to harness these materials and properties into useful electronic and photonic
devices. Techniques for harvesting nanoscience concepts and materials to control
electro-optical processes are anticipated which will enable a range of new
micro-electronics systems, including battery chargers integrated into blankets
or clothing or radio shells, airship/satellite solar arrays, self-powered
display screens imbedded at the pixel level with photovoltaic functionality, and
solid state image intensifier devices.

This project focuses on the new organic nanocomposite materials and
nano-structures enabled by nanoscience rather than the well known approach of
inorganic materials or thin film structures. Once developed for photovoltaic
applications, these new nano-structures may also be applied to other
electro-optic devices as noted above. Organic materials offer opportunities to
create devices with properties not available in inorganic. Phenomena to
transform electrical current into photons (e.g. displays) or to transform photon
fluxes into electrical current or voltage (photovoltaics, sensors) both involve
excitons when the material is solid state. Excitons can generate photons,
current, or heat. Controlling the fate of excitons is a matter of structure on
the nanoscale as the mean distance they travel before quenching into lattice
heating is about 20 nm. For organic light emitting diodes carefully tailored
structures know as thin films are used to force current to transform to excitons
only in a well defined emission layer where hole injection current from the one
side is in balance with electron injection current from the other; layers about
the emission layer also serve to confine the excitons. For organic photovoltaic
cells, novel nano-structures must be invented that control the locations of
exciton creation and generate an electromotive force to force their evolution
into holes and electrons which are separated to produce current from incident
light (infrared + visible + ultraviolet).

Page 1 of 5

<PAGE>

FA8650-04-C-6473 (NANOSYS)                                         ATTACHMENT #1

Areas of interest important to meeting the performance goals include (but are
not limited to) high electron and hole mobility materials, designs for the
efficient charge separation, improvements in excition diffusion properties,
methods to reduce recombination, materials to maximize solar absorption
efficiency, materials and designs to significantly reduce resistive loses,
improvements in flexible, transparent, high conductivity electrodes, and
materials to enhance the stability of organic solar cells to environmental
conditions. Other areas of interest include the control of three-dimensional
nanostructures, new methods to image resulting nanocomposite structures, and new
approaches for fabrication and manufacture of organic-based solar cells.
Well-coordinated, interdisciplinary research and development activities will be
needed to take into consideration all significant and relevant engineering
tradeoffs and optimizations.

Specifically excluded from this program are evolutionary improvements to the
existing state-of-practice, including approaches that utilize aqueous or
gel-based electrolytes and traditional, inorganic-based, thin film
photovoltaics. While conventional, inorganic, solar cells have improved over the
years they remain costly and energy intensive to manufacture.

This program is to demonstrate significant advances in organic, nanocomposite,
photovoltaic cells that perform competitively with inorganic semiconductor cells
(high efficiency, high carrier mobilities, efficient charge separation, and high
photochemical stability), but that will be flexible, lightweight, and low cost
and processed like a polymer. Nanocomposite materials are attractive for
photovoltaics because of the potential of high throughput, non-vacuum processes
using reel-to-reel, spray deposition, or other low cost processes. These
material systems also offer the potential for very thin and flexible
photovoltaic devices with high energy densities. Furthermore, with a flexible
substrate, the electronics package might be folded or rolled up for storage when
not operational.

For the purposes of this program, the term nanocomposite will include organic
nano-materials in organic matrices or inorganic nano-particles in organic
matrices with an unspecified format (thin films, bulk mixtures, etc). The
organic matrix may be an active electronic/photonic material or an inactive
binder containing the active components.

The results of this effort are expected to be applied to solar cells for
military applications. Among the potential DoD applications are solar powered
battery chargers (for dismounts, vehicles, aircraft, spacecraft), direct solar
powered electronics, direct aircraft power for propulsion, avionics,
communications (strato-based transponder farms), satellites, multifunction
electronics blankets for dismounts integrating sensors and antennae (EO, RF,
audio) with power-generation blankets. To meet the requirements for any of these
DoD applications the solar cells must be flexible, lightweight, durable, and low
cost. For example, Special Operations teams now use batteries to power
mission-critical equipment such as encrypted radios, laser designators, GPS
navigation sets, etc. On a mission of several days, these batteries can make up
about half the weight carried by a team. Current mission planning must trade off
the heavier weight of rechargeable batteries versus the greater number of
expendable batteries required. In logistics studies for a typical desert
reconnaissance mission, a recharging system powered by efficient solar cells
would allow battery weight to be reduced by more than a factor of two. The
weight savings would allow greater amounts of ammunition, water, clothing, or
food to be carried by the

Page 2 of 5

<PAGE>

FA8650-04-C-6473 (NANOSYS)                                         ATTACHMENT #1

Special Operations team. When teams operate for extended periods in denied
areas, efficient solar cells increase the level of covertness by allowing less
frequent re-supply.

3. REQUIREMENTS

The overall performance goal for this program is to demonstrate solar cell
technology having, in the same device, the following characteristics: external
photovoltaic (PV) cell efficiency > or = [*** Redacted]%; flexibility (bend
around [*** Redacted] radius); light weight ([*** Redacted] g/m(2)), and
environmental stability ([*** Redacted] continuous operation).

The performance goal for the basic effort is a coupon size [*** Redacted]
([*** Redacted]) device fabricated on a flexible substrate with PV cell
efficiency > or = [*** Redacted]%.

The performance goal for Option 1 is a [*** Redacted] ([*** Redacted]) device
fabricated on a plastic substrate with PV cell efficiency > or =
[*** Redacted]%.

Meeting the performance goals defined above for each phase will be required for
the program to continue to the next phase. The photovoltaic cell efficiency will
be measured using standard test conditions that include a cell temperature of
[*** Redacted] degrees C, total irradiance of [*** Redacted] kW/m(2), and a
spectrum defined by the American Society for Testing and Materials (ASTM)
document "G173-03 Standard Tables for Reference Solar Irradiance (at Air Mass
1.5): Direct Normal and Hemispherical on 37 degrees Tilted Surface," ASTM-
173-03 (January 2003), www.astm.org or www.rredc.nrel.gov/solar/spectra/am 1.5).
The cell efficiency will be independently verified by a DARPA-sponsored
Government laboratory.

Relevant materials and device design and characterization data, simulations and
cell test data to support the conclusions shall be reported.

3.1. PHASE 1 (BASE EFFORT)

During Phase 1 the Contractor shall evaluate various alternatives to best meet
the overall performance goal of the program and shall achieve of the specific
goal given above for Phase 1.

3.1.1. TASK 1.1: DEVELOPMENT OF NANOCOMPOSITE LAYER-1

The Contractor shall develop [*** Redacted] nanocrystal nanocomposite films for
Phase 1 devices by 9MAC.

3.1.2. TASK 1.2: ADVANCE MATERIAL SYNTHESIS - [*** Redacted] NANOCRYSTALS-1

The Contractor shall develop improved [*** Redacted] nanocrystals.

3.1.3. TASK 1.3: SUBSTRATE SELECTION AND DEVELOPMENT OF FLEXIBLE ELECTRODES-1

The contractor shall develop flexible substrate material and tailored electrode.

3.1.4. TASK 1.4; INTEGRATION, PROCESSING, FABRICATION AND TESTING-1

The contractor shall demonstrate shaped-nanocrystal nanocomposite PV cell
meeting the Phase 1 performance goal by 12 MAC.

Page 3 of 5

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

FA8650-04-C-6473 (NANOSYS)                                         ATTACHMENT #1

3.1.5. TASK 1.5: APPLICATION ANALYSIS-1

The contractor shall develop preliminary performance specifications for
applications in the form of a systems performance specification document and an
emulator.

3.1.6. TASK 1.6: PROGRAM MANAGEMENT-1

The contractor shall manage the program and provide oversight of all program
activities including those of its subcontractors, and provide all items listed
in Section 4. DELIVERABLES.

3.2. PHASE 2 (OPTION 1 EFFORT)

During Phase 2 the Contractor shall evaluate various alternatives to best meet
the overall performance goal of the program and shall achieve of the specific
goal given above for Phase 2.

3.2.1. TASK 2.1: DEVELOPMENT OF NANOCOMPOSITE LAYER-2

The Contractor shall develop [***Redacted] nanocrystal nanocomposite films for
Phase 2 PV devices.

3.2.2. TASK 2.2: ADVANCE MATERIAL SYNTHESIS - [***Redacted] NANOCRYSTALS-2

The Contractor shall develop optimized [***Redacted] nanocrystals for
preliminary PV testing.

3.2.3. TASK 2.3: ELECTRODE DEVELOPMENT-2

The Contractor shall develop matched flexible electrodes for both anode and
cathode.

3.2.4. TASK 2.4: INTEGRATION, PROCESSING, FABRICATION AND TESTING-2

The contractor shall demonstrate nanocomposite PV cell meeting the Phase 2
performance goal by 24MAC.

3.2.5. TASK 2.5: APPLICATION ANALYSIS-2

The contractor shall conduct preliminary testing for customer-specific
applications.

3.2.6. TASK 2.6: PROGRAM MANAGEMENT-2

The contractor shall manage the program and provide oversight of all program
activities including those of its subcontractors, and provide all items listed
in Section 4. DELIVERABLES.

4. DELIVERABLES

4.1 PHASE 1 (BASE EFFORT)

Final Report for Phase 1

Quarterly: Technical Management Report, Contract Funds Status Report,
Presentation Material

Monthly: Status Report, Contractor's Billing Voucher*,
Funds & Man-Hour Expenditure Report Demos of materials, devices, processes,
circuits and applications developed in Phase 1. Three (3) coupon-sized devices
with characteristics and performance required for Phase 1

4.2 PHASE 2 (OPTION 1 EFFORT)

Final Report for Phase 2

Quarterly: Technical Management Report, Contract Funds Status Report,
Presentation Material

Page 4 of 5

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>

FA8650-04-C-6473 (NANOSYS)                                         ATTACHMENT #1

Monthly: Status Report, Contractor's Billing Voucher*, Funds & Man-Hour
Expenditure Report Demos of materials, devices, processes, circuits and
applications developed in Phase 2. Three (3) small-sized devices with
characteristics and performance required for Phase 2

Page 5 of 5

<PAGE>

                    ATTACHMENT 2, CONTRACT FA8650-04-C-6473,
                     "FLEXIBLE NANOCOMPOSITE PHOTOVOLTAICS"

           IDENTIFICATION AND ASSERTION OF USE, RELEASE, OR DISCLOSURE
                            RESTRICTIONS (JUN 1995)

      (a) The terms used in this provision are defined in following clause or
      clauses contained in this solicitation--

            (1) If a successful offeror will be required to deliver technical
            data, the Rights in Technical Data--Noncommercial Items clause, or,
            if this solicitation contemplates a contract under the Small
            Business Innovative Research Program, the Rights in Noncommercial
            Technical Data and Computer Software--Small Business Innovative
            Research (SBIR) Program clause.

            (2) If a successful offeror will not be required to deliver
            technical data, the Rights in Noncommercial Computer Software and
            Noncommercial Computer Software Documentation clause, or, if this
            solicitation contemplates a contract under the Small Business
            Innovative Research Program, the Rights in Noncommercial Technical
            Data and Computer Software--Small Business Innovative Research
            (SBIR) Program clause.

      (b) The identification and assertion requirements in this provision apply
      only to technical data, including computer software documentation, or
      computer software to be delivered with other than unlimited rights. For
      contracts to be awarded under the Small Business Innovative Research
      Program, the notification and identification requirements do not apply to
      technical data or computer software that will be generated under the
      resulting contract. Notification and identification is not required for
      restrictions based solely on copyright.

      (c) Offers submitted in response to this solicitation shall identify, to
      the extent known at the time an offer is submitted to the Government, the
      technical data or computer software that the Offeror, its subcontractors
      or suppliers, or potential subcontractors or suppliers, assert should be
      furnished to the Government with restrictions on use, release, or
      disclosure.

      (d) The Offeror's assertions, including the assertions of its
      subcontractors or suppliers or potential subcontractors or suppliers,
      shall be submitted as an attachment to its offer in the following format,
      dated and signed by an official authorized to contractually obligate the
      Offeror:

 Identification and Assertion of Restrictions on the Government's Use, Release,
             or Disclosure of Technical Data or Computer Software.

<PAGE>

            The Offeror asserts for itself, or the persons identified below,
            that the Government's rights to use, release, or disclose the
            following technical data or computer software should be restricted:

<TABLE>
<CAPTION>
  Technical Data
 Computer Software                                              Name of Person
  to be Furnished           Basis for      Asserted Rights        Asserting
With Restrictions*         Assertion**       Category***       Restrictions****
------------------         -----------       -----------       ----------------
<S>                        <C>             <C>                 <C>
   (LIST)*****               (LIST)            (LIST)               (LIST)
</TABLE>

*For technical data (other than computer software documentation) pertaining to
items, components, or processes developed at private expense, identify both the
deliverable technical data and each such item, component, or process. For
computer software or computer software documentation identify the software or
documentation.

**Generally, development at private expense, either exclusively or partially,
is the only basis for asserting restrictions. For technical data, other than
computer software documentation, development refers to development of the item,
component, or process to which the data pertain. The Government's rights in
computer software documentation generally may not be restricted. For computer
software, development refers to the software. Indicate whether development was
accomplished exclusively or partially at private expense. If development was not
accomplished at private expense, or for computer software documentation, enter
the specific basis for asserting restrictions.

***Enter asserted rights category (e.g., government purpose license rights from
a prior contract, rights in SBIR data generated under another contract, limited,
restricted, or government purpose rights under this or a prior contract, or
specially negotiated licenses).

****Corporation, individual, or other person, as appropriate.

*****Enter "none" when all data or software will be submitted without
restrictions.

            NOTE: SEE ATTACHED FOR CONTRACTOR'S SIGNATURE AND LIST OF TECHNICAL
            DATA OR COMPUTER SOFTWARE TO BE DELIVERED WITH LIMITED RIGHTS.

<PAGE>

PART IV - REPRESENTATIONS AND INSTRUCTIONS
SECTION K - REPRESENTATIONS, CERTIFICATIONS AND OTHER STATEMENTS OF OFFERORS

***Enter asserted rights category (e.g., government purpose license rights from
a prior contract, rights in SBIR data generated under another contract, limited,
restricted, or government purpose rights under this or a prior contract, or
specially negotiated licenses).

****Corporation, individual, or other person, as appropriate.

*****Enter "none" when all data or software will be submitted without
restrictions.

          Date                   June 21, 2004.

          Printed Name and Title Karen L. Vergura

                                 VP Finance

          Signature              /s/ Karen L. Vergura
                                 --------------------------

          (End of identification and assertion)

      (e) An offerer's failure to submit, complete, or sign the notification and
identification required by paragraph (d) of this provision with its offer may
render the offer ineligible for award.

      (f) If the Offeror is awarded a contract, the assertions identified in
paragraph (d) of this provision shall be listed in an attachment to that
contract. Upon request by the Contracting Officer, the Offeror shall provide
sufficient information to enable the Contracting Officer to evaluate any listed
assertion.

252.247-7022 REPRESENTATION OF EXTENT OF TRANSPORTATION BY SEA (AUG 1992)

      (a) The Offeror shall indicate by checking the appropriate blank in
paragraph (b) of this provision whether transportation of supplies by sea is
anticipated under the resultant contract. The term "supplies" is defined in the
Transportation of Supplies by Sea clause of this solicitation.

      (b) Representation, The Offerer represents that it--

      [ ] Does anticipate that supplies will be transported by sea in the
performance of any contract or subcontract resulting from this solicitation.

      [X] Does not anticipate that supplies will be transported by sea in the
performance of any contract or subcontract resulting from this solicitation.

      (c) Any contract resulting from this solicitation will include the
Transportation of Supplies by Sea clause. If the Offeror represents that it will
not use ocean transportation, the resulting contract will also include the
Defense FAR Supplement clause at 252.247-7024, Notification of Transportation of
Supplies by Sea.

                                                     SECTION K PA8650-04-C-6473

                                                              PAGE K- 11 of 11

<PAGE>

Nanosys, Inc.
Addendum A
252.227-7017 Identification and Assertion of Use, elease
or Disclosure Restrictions (June 1995)

<TABLE>
<CAPTION>
Technical Data or Computer Software to be Delivered with                            Assorted Rights    Name of Person Asserting
                     Restrictions                          Basis for Assertion         Category               Restrictions
-------------------------------------------------------- ----------------------   -------------------  ------------------------
                      (List)                                     (List)                 (List)                   (List)
                      ------                                     ------                 ------                   ------
<S>                                                      <C>                      <C>                  <C>
[***Redacted]                                            Pre-existing             Limited Rights Data       Matthew Murphy
                                                         intellectual property
                                                         developed with private
                                                         funds

[***Redacted]                                            Pre-existing             Limited Rights Data       Matthew Murphy
                                                         intellectual property
                                                         developed with private
                                                         funds

[***Redacted]                                            Pre-existing             Limited Rights Data       Matthew Murphy
                                                         intellectual property
                                                         developed with private
                                                         funds

[***Redacted]                                            Pre-existing             Limited Rights Data       Matthew Murphy
                                                         intellectual property
                                                         developed with private
                                                         funds

[***Redacted]                                            Pre-existing             Limited Rights Data       Matthew Murphy
                                                         intellectual property
                                                         developed with private
                                                         funds
</TABLE>

*** Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00068-of-00352.parquet"}]]